Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,5.331396054153146e-32,14.509569377990431,1044.8211751879296,"['RPL30', 'RPL3', 'RPL32', 'RPL34', 'RPLP1', 'RPLP0', 'RPL10A', 'RPL8', 'RPL9', 'RPL6', 'RPL7', 'RPS4X', 'RPS15', 'RPL7A', 'RPS14', 'RPS16', 'RPL18A', 'RPS19', 'RPS18', 'RPL35', 'RPLP2', 'RPL38', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPS7', 'RPL21', 'RPL23', 'RPS5', 'RPL13A', 'RPSA', 'RPS3A', 'RPL37A', 'RPL24', 'RPL27', 'RPL26', 'RPL29', 'UBA52', 'RPL10', 'RPL12', 'RPL11', 'RPL36A', 'RPS15A', 'RPL14', 'RPL13', 'RPS2', 'RPL15', 'RPS27A', 'RPL18', 'RPL17', 'RPL19', 'RPL41', 'RPL35A', 'RPL23A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPL27A', 'FAU', 'RPS21', 'RPS24', 'RPS23']",2.8736224731885455e-29,0,0,65
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,3.775614733515644e-14,5.459200972082039,168.7309533090803,"['NDUFB9', 'COX7B', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB5', 'COX4I1', 'COX17', 'NDUFB3', 'NDUFB2', 'ATP5MC3', 'COX7A2', 'UQCR11', 'UQCR10', 'COX6A1', 'COX5B', 'COX7A1', 'COX7C', 'UQCRH', 'ATP5MC1', 'ATP5IF1', 'ATP5F1B', 'UCP3', 'UQCRFS1', 'ATP5MF', 'ATP5ME', 'COX8A', 'ATP5PF', 'NDUFA7', 'NDUFA6', 'NDUFA4', 'NDUFA3', 'NDUFA2', 'NDUFA1', 'NDUFC2', 'NDUFC1', 'COX6C', 'ATP5F1D', 'ATP5F1E', 'COX6B1', 'UQCRQ', 'NDUFS6', 'NDUFS5', 'SLC25A5', 'SLC25A4', 'SLC25A6']",1.0175281706824661e-11,0,0,46
3,Nonalcoholic fatty liver disease WP4396,1.3330580645919223e-07,2.7806152458630695,44.01886346632353,"['NDUFB9', 'NDUFA13', 'COX7B', 'GSK3A', 'NDUFB7', 'NDUFA11', 'UQCRB', 'NDUFB10', 'NDUFB11', 'NDUFB5', 'COX4I1', 'NDUFB3', 'NDUFB2', 'COX7A2', 'UQCR11', 'UQCR10', 'COX6A1', 'COX5B', 'COX7A1', 'COX7C', 'UQCRH', 'CASP7', 'CASP8', 'LEPR', 'UQCRFS1', 'CYC1', 'COX8A', 'XBP1', 'JUN', 'NDUFA7', 'TGFB1', 'NDUFA6', 'NDUFA4', 'NDUFA3', 'NDUFA2', 'NDUFA1', 'NDUFC2', 'NDUFC1', 'COX6C', 'UQCRHL', 'COX6B1', 'UQCRQ', 'NDUFS6', 'DDIT3', 'NDUFS5', 'CYCS', 'BAX']",2.395060989383487e-05,0,0,47
4,Oxidative phosphorylation WP623,1.7957009849142088e-07,4.645265093472265,72.15350997400034,"['NDUFB9', 'NDUFB7', 'NDUFA11', 'NDUFB10', 'NDUFB5', 'NDUFB2', 'ATP5MC3', 'ATP5MC1', 'ATP5F1B', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'NDUFA7', 'NDUFA6', 'ATP6AP1', 'NDUFA4', 'NDUFA3', 'ATP6AP2', 'NDUFA2', 'NDUFC2', 'NDUFC1', 'ATP5F1D', 'ATP5F1E', 'NDUFS6', 'NDUFS5']",2.4197070771718962e-05,0,0,25
5,Mitochondrial CIV Assembly WP4922,2.1703535116920273e-05,4.817784835252084,51.73354412050342,"['COX8A', 'COA3', 'COX7B', 'PET100', 'NDUFA4', 'COX4I1', 'COX17', 'COX7A2', 'COX6A1', 'HIGD1A', 'COX5B', 'COX6C', 'COX7C', 'COX6B1', 'SCO2', 'COX14']",0.002339641085604005,0,0,16
6,Proximal tubule transport WP4917,4.8465375946290365e-05,4.09539316918189,40.686342441164804,"['SLC47A2', 'ATP6V1G1', 'SLC13A3', 'ATP6V0B', 'SLC22A6', 'ABCC2', 'ABCB1', 'SLC3A1', 'SLC4A2', 'ATP1B1', 'SLC7A7', 'SLC7A9', 'ATP6V0A4', 'ATP6V1E1', 'ATP6V0C', 'SLC26A6', 'ATP6V1F']",0.004353806272508418,0,0,17
7,Allograft Rejection WP2328,7.36694981716402e-05,3.900052952078369,37.11259855345549,"['C1QB', 'C1QA', 'ABCB1', 'TGFB1', 'HLA-B', 'HLA-A', 'HLA-E', 'C2', 'VEGFA', 'C3', 'TUBA1B', 'CASP7', 'CASP8', 'C6', 'IL5', 'CXCL12', 'VIM']",0.005271648293516996,0,0,17
8,"GPCRs, Class A Rhodopsin-like WP455",7.824338840099437e-05,2.541233322828028,24.029104926171613,"['NPFFR2', 'GPR27', 'NPFFR1', 'CHRM5', 'HTR2B', 'ADRA1D', 'MCHR1', 'MC4R', 'HRH1', 'HTR7', 'GPER1', 'NTSR1', 'P2RY12', 'GPR39', 'HTR1F', 'P2RY14', 'NPY1R', 'OPRK1', 'NMBR', 'GPR3', 'SSTR1', 'ADRA2C', 'ADRA2A', 'HCRTR2', 'ADORA2A', 'LPAR6', 'ACKR4', 'OR6A2', 'RGL4', 'OR3A2']",0.005271648293516996,0,0,30
9,Mitochondrial complex I assembly model OXPHOS system WP4324,0.00012050340645672865,3.21325381047051,28.99586428161547,"['NDUFB9', 'NDUFA13', 'NDUFA7', 'NDUFB7', 'NDUFA6', 'NDUFB10', 'NDUFB11', 'NDUFB5', 'NDUFA3', 'NDUFB3', 'NDUFA2', 'NDUFB2', 'NDUFA1', 'NDUFC2', 'NDUFC1', 'TMEM70', 'NDUFS6', 'NDUFS5', 'NDUFAF4', 'NDUFAF3']",0.007216815120019637,0,0,20
10,Selenium Micronutrient Network WP15,0.0002269030107374121,3.011928429423459,25.273054998707757,"['SERPINA3', 'GPX2', 'GPX4', 'DIO1', 'KMO', 'SELENOK', 'SELENOH', 'SOD1', 'PRDX3', 'PRDX2', 'SELENOM', 'PRDX5', 'RFK', 'ALOX5', 'PRDX1', 'SELENOW', 'PNPO', 'SEPHS2', 'LDLR', 'MSRB1']",0.012230072278746512,0,0,20
11,Complement system WP2806,0.00045201075154704376,3.1487444247571332,24.251014269019404,"['PRNP', 'FKBP2', 'F10', 'C5AR1', 'WAS', 'F13A1', 'C4BPA', 'LRP2', 'DCN', 'C2', 'C3', 'C6', 'RPS19', 'SPP1', 'MASP2', 'CD59', 'CALR']",0.022148526825805145,0,0,17
12,Computational Model of Aerobic Glycolysis WP4629,0.0007805833931521875,8.409414556962025,60.17330498472334,"['LDHA', 'TPI1', 'PKM', 'PGK1', 'ENO1', 'ALDOA', 'GAPDH']",0.035061204075752424,0,0,7
13,TYROBP causal network in microglia WP3945,0.0013466829488412845,3.6076099881093935,23.84670169057142,"['APBB1IP', 'C3', 'CD4', 'SLC7A7', 'IGSF6', 'ADAP2', 'LOXL3', 'IL18', 'SPP1', 'LHFPL2', 'SAMSN1', 'TMEM106A']",0.05583554687888095,0,0,12
14,Mitochondrial complex III assembly WP4921,0.001584256032360137,5.492679066086268,35.414819242343654,"['UQCRB', 'UQCC3', 'UQCRQ', 'UQCRFS1', 'UQCR11', 'UQCR10', 'CYC1', 'UQCRH']",0.05729134749386335,0,0,8
15,Galanin receptor pathway WP4970,0.001594378872742023,6.726977848101265,43.33028760015309,"['CDKN1C', 'YAP1', 'CDKN1A', 'CDKN1B', 'PRKCD', 'VAMP2', 'VEGFA']",0.05729134749386335,0,0,7
16,Glycolysis and Gluconeogenesis WP534,0.0019401855182247876,3.3951178568930547,21.202414875142413,"['LDHA', 'TPI1', 'PKM', 'GOT1', 'MDH2', 'PGAM1', 'PGK1', 'ALDOC', 'ENO1', 'ENO2', 'ALDOA', 'GAPDH']",0.06535999964519754,0,0,12
17,Vitamin D Receptor Pathway WP2877,0.0025479638531499624,2.0540219145502423,12.267565218557793,"['COLEC11', 'CDKN1A', 'ABCB1', 'CDKN1B', 'ATP2C2', 'CYP3A5', 'ADAMTS5', 'DUSP10', 'CCND1', 'BGLAP', 'CLMN', 'ALOX5', 'DND1', 'TIMP2', 'SPP1', 'SOSTDC1', 'LGALS9', 'TGFB1', 'CDKN2C', 'IGFBP5', 'GADD45A', 'IGFBP3', 'G0S2', 'CEACAM1', 'PNOC', 'ZNF257']",0.0807854421675194,0,0,26
18,Complement Activation WP545,0.0029271910983926864,7.205219454329774,42.03317508716082,"['C1QB', 'C3', 'C1QA', 'C6', 'MASP2', 'C2']",0.0876531112240921,0,0,6
19,Complement and Coagulation Cascades WP558,0.0034394913794716514,3.305665610142631,18.751162308421318,"['C1QB', 'C3', 'C1QA', 'CPB2', 'C6', 'SERPIND1', 'F10', 'C5AR1', 'MASP2', 'F5', 'C2']",0.09757293965974842,0,0,11
20,Peptide GPCRs WP24,0.004793664907619667,3.110958329449054,16.6139486560333,"['MC4R', 'C5AR1', 'GNRHR', 'NPY1R', 'TAC4', 'OPRK1', 'SSTR1', 'NMBR', 'NTSR1', 'TSHR', 'HCRTR2']",0.11864747903309854,0,0,11
21,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.005012542113073668,4.8041930379746836,25.44210354809362,"['CD63', 'EGF', 'CD81', 'SPP1', 'HSPB1', 'PDLIM5', 'SOD1']",0.11864747903309854,0,0,7
22,Control of immune tolerance by vasoactive intestinal peptide WP4484,0.005136927545115112,inf,inf,"['TGFB1', 'IL5', 'VIP']",0.11864747903309854,0,0,3
23,Gastric acid production WP2596,0.005136927545115112,inf,inf,"['CCK', 'VIP', 'MUC6']",0.11864747903309854,0,0,3
24,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.005503129825282864,5.763701067615658,29.98529912313133,"['CDKN1A', 'GALNT3', 'CCND1', 'SPP1', 'ROS1', 'PHEX']",0.11864747903309854,0,0,6
25,Glycolysis in senescence WP5049,0.005503129825282864,5.763701067615658,29.98529912313133,"['LDHA', 'PKM', 'PGK1', 'ALDOC', 'ENO1', 'GAPDH']",0.11864747903309854,0,0,6
26,Cholesterol Biosynthesis Pathway WP197,0.008012300728915305,4.203322784810126,20.288503116081543,"['IDI1', 'SQLE', 'HMGCS1', 'MSMO1', 'HMGCR', 'DHCR7', 'FDFT1']",0.16610115741866727,0,0,7
27,Drug Induction of Bile Acid Pathway WP2289,0.009885257383781522,9.60094824180166,44.32480129305352,"['ABCB1', 'ABCC2', 'SLC10A1', 'SLC51A']",0.1902912046377943,0,0,4
28,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.009885257383781522,9.60094824180166,44.32480129305352,"['HEY1', 'VEGFB', 'VEGFC', 'VEGFA']",0.1902912046377943,0,0,4
29,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.014914193917482676,1.9679271860439917,8.276003459227661,"['HSPA8', 'HSPA1L', 'HSPA5', 'TUBB', 'UBE2L6', 'TUBA4A', 'PSMD8', 'TUBB8', 'TUBA1B', 'TUBB6', 'TUBB2B', 'CASP8', 'TUBA1A', 'TUBB2A', 'TUBB3', 'STUB1', 'HSPA1B', 'HSPA1A']",0.26874311887360836,0,0,18
30,Cori Cycle WP1946,0.01495787303563683,4.116251482799526,17.29861886331228,"['LDHA', 'TPI1', 'PGAM1', 'PGK1', 'ALDOA', 'GAPDH']",0.26874311887360836,0,0,6
31,Senescence and Autophagy in Cancer WP615,0.01704391742660102,1.7943709658926126,7.306610186184294,"['GABARAPL2', 'GABARAPL1', 'JUN', 'CDKN1A', 'CEBPB', 'TGFB1', 'CDKN1B', 'PCNA', 'IGFBP5', 'IGFBP3', 'FN1', 'HMGA1', 'CXCL14', 'GABARAP', 'BMP2', 'MAP1LC3B', 'MAP1LC3A', 'IFI16', 'IRF1', 'FKBP8', 'HRAS', 'SLC39A3']",0.2963442417076758,0,0,22
32,Oxidative Damage WP3941,0.018844770805590154,2.402931854199683,9.543291471649377,"['C1QB', 'CDKN1C', 'C1QA', 'CDKN1A', 'PCNA', 'CDKN1B', 'GADD45A', 'C5AR1', 'CYCS', 'NFKBIE', 'C2']",0.31591144558720585,0,0,11
33,Exercise-induced Circadian Regulation WP410,0.019863592321010943,2.1033320111067035,8.242677891993688,"['IDI1', 'DAZAP2', 'HSPA8', 'CEBPB', 'RBPMS', 'GSTP1', 'G0S2', 'PER2', 'DNAJA1', 'CLDN5', 'TUBB3', 'UCP3', 'SUMO3', 'EIF4G2']",0.31591144558720585,0,0,14
34,NAD Biosynthesis II (from tryptophan) WP2485,0.019927623654851574,6.400105360200184,25.060562226745127,"['TDO2', 'NMNAT1', 'HAAO', 'KMO']",0.31591144558720585,0,0,4
35,IL-18 signaling pathway WP4754,0.022167734213214316,1.459402482309588,5.559035478216159,"['BTG2', 'CEBPB', 'EPB41', 'CD81', 'RGS16', 'MEPCE', 'COX17', 'HSPB1', 'ENO1', 'PLD1', 'RND2', 'ACACB', 'ADAMTS5', 'CASP8', 'TMSB4X', 'FAM186B', 'SPP1', 'FADD', 'JUN', 'TICAM2', 'USP5', 'IMP3', 'PRKCD', 'FN1', 'IL18', 'NDUFC1', 'BPGM', 'EEF2', 'VEGFA', 'CCNA2', 'NR4A1', 'ARL4D', 'BMP2', 'IRF1', 'RFX5', 'CYCS', 'BAX', 'LTB', 'NFKBIE', 'SNTB1', 'ITM2C', 'ARF6', 'MYH7']",0.3356305854758954,0,0,43
36,Hypertrophy Model WP516,0.022416885115273164,3.601423487544484,13.677993216897114,"['NR4A3', 'MSTN', 'WDR1', 'IL1R1', 'IL18', 'VEGFA']",0.3356305854758954,0,0,6
37,Development and heterogeneity of the ILC family WP3893,0.02817710762313983,4.000658761528327,14.279332950080247,"['IL5', 'NFIL3', 'IL7', 'ID2', 'IL18']",0.41047191915871273,0,0,5
38,Thyroxine (Thyroid Hormone) Production WP1981,0.02978141980083217,inf,inf,"['TG', 'TSHR']",0.4224259282275932,0,0,2
39,Bile acids synthesis and enterohepatic circulation  WP4389,0.034471804748043476,4.799683919399447,16.16348056793012,"['ABCG5', 'SLC10A1', 'FGFR4', 'LDLR']",0.4645075689798858,0,0,4
40,Mammary gland development pathway - Puberty (Stage 2 of 4) WP2814,0.034471804748043476,4.799683919399447,16.16348056793012,"['CCND1', 'EGF', 'FN1', 'VIM']",0.4645075689798858,0,0,4
41,EV release from cardiac cells and their functional effects WP3297,0.038999056476968316,7.197867298578199,23.351449399542187,"['CXCL12', 'RGS16', 'MYB']",0.5126949131972176,0,0,3
42,Nuclear Receptors Meta-Pathway WP2882,0.04117598562715879,1.3678456814923936,4.363291029246983,"['CDKN1C', 'ABCB1', 'CDKN1B', 'HSP90AB1', 'SRXN1', 'ABCB4', 'GSTP1', 'SLC5A3', 'CYP3A5', 'SLC5A4', 'CYP3A7', 'DNAJB1', 'RGS2', 'CCND1', 'CPT2', 'PRDX1', 'SLCO2B1', 'SLC39A8', 'SLC39A7', 'CBR3', 'SLC39A3', 'GSTM2', 'JUN', 'ABCG5', 'HSP90AA1', 'GPX2', 'TGFB1', 'ABCC2', 'GADD45B', 'SLC10A1', 'TSC22D3', 'SLC2A12', 'SLC39A11', 'AIP', 'SLC2A9', 'SLC7A5', 'B3GNT5', 'MAFF', 'SPINK13', 'BAX', 'SPRY1', 'ANGPTL4', 'MFGE8', 'GSTM5', 'HSPA1A', 'FKBP5']",0.5209073820436563,0,0,46
43,Dopaminergic Neurogenesis WP2855,0.04158085207128536,3.4288537549407114,10.904150988500826,"['CDKN1C', 'TGFB1', 'ASCL1', 'SLC18A2', 'GLI2']",0.5209073820436563,0,0,5
44,Monoamine GPCRs WP58,0.04252305159540051,2.4012663237039966,7.582500184775409,"['HRH1', 'HTR7', 'HTR1F', 'CHRM5', 'HTR2B', 'ADRA1D', 'ADRA2C', 'ADRA2A']",0.5209073820436563,0,0,8
45,Spinal Cord Injury WP2431,0.04483571905039154,1.6299491188462445,5.060584782646783,"['C1QB', 'BTG2', 'TGFB1', 'CDKN1B', 'IL1R1', 'GADD45A', 'MIF', 'PDYN', 'NTN1', 'GFAP', 'TNFSF13B', 'RHOB', 'NR4A1', 'ZFP36', 'CCND1', 'SLIT3', 'LTB', 'SLIT2', 'VIM', 'ROS1']",0.5370322792924676,0,0,20
46,Cytokines and Inflammatory Response WP530,0.053730108391450405,3.8394310549190043,11.225658475277,"['CD4', 'TGFB1', 'IL5', 'IL7']",0.6033443421456618,0,0,4
47,Farnesoid X receptor pathway WP2879,0.053730108391450405,3.8394310549190043,11.225658475277,"['SLC10A1', 'ABCB4', 'SLCO2B1', 'FKBP5']",0.6033443421456618,0,0,4
48,Trans-sulfuration pathway WP2333,0.053730108391450405,3.8394310549190043,11.225658475277,"['MPST', 'AHCY', 'GOT1', 'MAT2B']",0.6033443421456618,0,0,4
49,Type II interferon signaling (IFNG) WP619,0.056317443976190706,2.4007120253164556,6.9062506045655425,"['CIITA', 'SPI1', 'IRF1', 'PRKCD', 'IFI6', 'HLA-B', 'ISG15']",0.6160784371815232,0,0,7
50,Nanomaterial induced apoptosis WP2507,0.058293135985635784,2.6185700420575864,7.4426855051808145,"['CASP7', 'ENDOG', 'CASP8', 'BAX', 'CYCS', 'FADD']",0.6160784371815232,0,0,6
51,Nuclear Receptors in Lipid Metabolism and Toxicity WP299,0.058293135985635784,2.6185700420575864,7.4426855051808145,"['CYP26A1', 'ABCD2', 'ABCG5', 'ABCB1', 'ABCC2', 'ABCB4']",0.6160784371815232,0,0,6
52,NRF2 pathway WP2884,0.08572924397270902,1.4485660864872525,3.5584913523892254,"['GSTM2', 'HSP90AA1', 'GPX2', 'TGFB1', 'HSP90AB1', 'ABCC2', 'SRXN1', 'GSTP1', 'SLC2A12', 'SLC39A11', 'SLC5A3', 'SLC5A4', 'SLC2A9', 'DNAJB1', 'PRDX1', 'MAFF', 'SLC39A8', 'SLC39A7', 'SLC39A3', 'GSTM5', 'CBR3', 'HSPA1A']",0.8863106740436728,0,0,22
53,Sleep regulation WP3591,0.08715114234566727,2.1002768987341773,5.124909602270323,"['CHRNB2', 'AHCY', 'ADORA2A', 'IL18', 'CRH', 'PTGDS', 'HCRTR2']",0.8863106740436728,0,0,7
54,Ovarian infertility WP34,0.0944007391624659,2.2153481157039874,5.22867874719134,"['CEBPB', 'CDKN1B', 'MSH5', 'ZP3', 'INHA', 'PRLR']",0.9389756096360368,0,0,6
55,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.09581383771796292,1.920379897111199,4.503959459374181,"['NDUFA13', 'CASP7', 'HSP90AA1', 'CASP8', 'ACAP1', 'IL18', 'NLRC4', 'AAMP']",0.9389756096360368,0,0,8
56,Dual hijack model of Vif in HIV infection WP3300,0.10425188213377405,3.5983412322274884,8.135652928624802,"['UBB', 'ELOB', 'RUNX1']",0.9841288061445158,0,0,3
57,Mevalonate pathway WP3963,0.10425188213377405,3.5983412322274884,8.135652928624802,"['HMGCS1', 'HMGCR', 'ACAT2']",0.9841288061445158,0,0,3
58,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.10589883257213714,2.7419992097984984,6.156531445722007,"['PTTG1', 'BUB3', 'ANAPC11', 'MAD2L1']",0.9841288061445158,0,0,4
59,Glucocorticoid Receptor Pathway WP2880,0.11223216845043522,1.60073985995508,3.501115204101581,"['CDKN1C', 'RGS2', 'HSP90AA1', 'MGAM', 'JUN', 'GADD45B', 'TSC22D3', 'B3GNT5', 'SPINK13', 'SPRY1', 'ANGPTL4', 'MFGE8']",0.9999950490537614,0,0,12
60,Pathogenic Escherichia coli infection WP2272,0.11223216845043522,1.60073985995508,3.501115204101581,"['TUBB8', 'TUBA1B', 'TUBB6', 'TUBB2B', 'TUBA1A', 'TUBB2A', 'TUBB3', 'TUBB', 'WAS', 'ACTB', 'TUBA4A', 'ACTG1']",0.9999950490537614,0,0,12
61,Cytosolic DNA-sensing pathway WP4655,0.1248714064623223,1.6005018489170628,3.32979739323733,"['CASP8', 'RNF125', 'TRADD', 'POLR1C', 'IL18', 'POLR2E', 'ISG15', 'FADD', 'POLR3K', 'POLR2K', 'POLR2L']",0.9999950490537614,0,0,11
62,Aryl Hydrocarbon Receptor Pathway WP2873,0.12580487867540688,1.8666051336146272,3.869515661851573,"['SLC7A5', 'HSP90AA1', 'JUN', 'CDKN1B', 'TGFB1', 'AIP', 'BAX']",0.9999950490537614,0,0,7
63,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.12601253501252718,1.3348826914563967,2.7650411569699447,"['VIPR1', 'DLX2', 'CEBPB', 'YWHAB', 'CDCA7L', 'ATP1A3', 'ASCL1', 'MYB', 'TAC1', 'YWHAG', 'YWHAH', 'CHRNB2', 'JUN', 'TSPYL1', 'SSTR1', 'VEGFA', 'PRKAR1A', 'SST', 'KCNQ1', 'PAH', 'CHRFAM7A', 'ALDOA', 'GAPDH', 'SLC25A4', 'VAMP2']",0.9999950490537614,0,0,25
64,Kynurenine Pathway and links to Cellular Senescence WP5044,0.12716330292888134,2.1812791951131874,4.498415370288476,"['CDKN1A', 'TDO2', 'HAAO', 'KMO', 'ACMSD']",0.9999950490537614,0,0,5
65,Pregnane X receptor pathway WP2876,0.12716330292888134,2.1812791951131874,4.498415370288476,"['HSP90AA1', 'ABCB1', 'ABCC2', 'CYP3A5', 'CYP3A7']",0.9999950490537614,0,0,5
66,Base Excision Repair WP4752,0.1322702371389368,1.745512105622909,3.531010748357611,"['FEN1', 'PCNA', 'NEIL2', 'TDG', 'POLD1', 'POLE2', 'POLE3', 'APEX2']",0.9999950490537614,0,0,8
67,Lung fibrosis WP3624,0.1322702371389368,1.745512105622909,3.531010748357611,"['CEBPB', 'TGFB1', 'IL5', 'EGF', 'SFTPC', 'FAM13A', 'SPP1', 'FGF1']",0.9999950490537614,0,0,8
68,Fas ligand pathway and stress induction of heat shock proteins WP314,0.13653295906408996,1.6617029051708387,3.308764936807806,"['CASP7', 'JUN', 'CASP8', 'MAPKAPK3', 'HSPB1', 'CYCS', 'FADD', 'ACTB', 'ACTG1']",0.9999950490537614,0,0,9
69,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,0.1380578375113139,2.3990517581983406,4.750320569082347,"['BMP2', 'SST', 'DKK1', 'DCN']",0.9999950490537614,0,0,4
70,ID signaling pathway WP53,0.1380578375113139,2.3990517581983406,4.750320569082347,"['PAX8', 'ID2', 'ID3', 'ELK3']",0.9999950490537614,0,0,4
71,Unfolded protein response WP4925,0.13995216892344994,1.919652036378015,3.7749085107142806,"['PPP1R15A', 'XBP1', 'CASP8', 'HSPA5', 'DDIT3', 'TXNIP']",0.9999950490537614,0,0,6
72,Cells and molecules involved in local acute inflammatory response  WP4493,0.14025054926694677,4.7966837741808135,9.422244982897109,"['C3', 'C6']",0.9999950490537614,0,0,2
73,Codeine and Morphine Metabolism WP1604,0.14025054926694677,4.7966837741808135,9.422244982897109,"['ABCB1', 'ABCC2']",0.9999950490537614,0,0,2
74,Nucleotide GPCRs WP80,0.14025054926694677,4.7966837741808135,9.422244982897109,"['ADORA2A', 'LPAR6']",0.9999950490537614,0,0,2
75,Robo4 and VEGF Signaling Pathways Crosstalk WP3943,0.14025054926694677,4.7966837741808135,9.422244982897109,"['SLIT2', 'VEGFA']",0.9999950490537614,0,0,2
76,HIF1A and PPARG regulation of glycolysis WP2456,0.14611994989707955,2.878436018957346,5.536174921815041,"['LDHA', 'TPI1', 'GAPDH']",0.9999950490537614,0,0,3
77,Pathogenesis of SARS-CoV-2 Mediated by nsp9-nsp10 Complex WP4884,0.14611994989707955,2.878436018957346,5.536174921815041,"['MMP25', 'CD4', 'CD247']",0.9999950490537614,0,0,3
78,Selective expression of chemokine receptors during T-cell polarization WP4494,0.14611994989707955,2.878436018957346,5.536174921815041,"['CD4', 'TGFB1', 'IL5']",0.9999950490537614,0,0,3
79,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.1528026785938671,1.6694826310627828,3.1363032134474222,"['LDHA', 'ANGPT2', 'PKM', 'ANGPT1', 'IGFBP3', 'PGK1', 'BAX', 'VEGFA']",0.9999950490537614,0,0,8
80,Vitamin A and carotenoid metabolism WP716,0.1528026785938671,1.6694826310627828,3.1363032134474222,"['CYP26A1', 'ALDH1A3', 'ABCG5', 'RBP4', 'RBP2', 'ALDH1A2', 'CRABP1', 'BCO1']",0.9999950490537614,0,0,8
81,Apoptosis Modulation by HSP70 WP384,0.15585921469282973,1.9993412384716733,3.716379790898401,"['CASP7', 'CASP8', 'CYCS', 'FADD', 'HSPA1A']",0.9999950490537614,0,0,5
82,Imatinib and Chronic Myeloid Leukemia WP3640,0.15585921469282973,1.9993412384716733,3.716379790898401,"['SPRED2', 'ABCB1', 'CDKN1B', 'GADD45A', 'PIM1']",0.9999950490537614,0,0,5
83,Pyrimidine metabolism WP4022,0.1650960747585646,1.360630129732592,2.4508046835804644,"['POLR2J3', 'ENTPD1', 'NME2', 'DCK', 'NME1', 'TYMP', 'NT5C', 'POLD1', 'POLE2', 'POLR1C', 'POLE3', 'POLR2E', 'POLR2I', 'DCTPP1', 'POLR3K', 'POLR2K', 'POLR2L']",0.9999950490537614,0,0,17
84,Cell cycle WP179,0.167343691052059,1.309937079626817,2.341781788914831,"['CDKN1C', 'ANAPC13', 'CDKN1A', 'TGFB1', 'CDKN1B', 'PCNA', 'CDKN2C', 'GADD45B', 'GADD45A', 'YWHAB', 'CDC14A', 'ANAPC11', 'GADD45G', 'SMC1B', 'CCNA2', 'CCND1', 'PTTG1', 'BUB3', 'YWHAG', 'SKP1', 'YWHAH']",0.9999950490537614,0,0,21
85,Catalytic cycle of mammalian Flavin-containing MonoOxygenases (FMOs) WP688,0.1726013664701739,inf,inf,['FMO5'],0.9999950490537614,0,0,1
86,"COVID-19, thrombosis and anticoagulation WP4927",0.1726013664701739,inf,inf,['F13A1'],0.9999950490537614,0,0,1
87,Major receptors targeted by epinephrine and norepinephrine WP4589,0.17354122762308447,2.1323148513982177,3.734408472316935,"['ADCY10', 'ADRA1D', 'ADRA2C', 'ADRA2A']",0.9999950490537614,0,0,4
88,miRNAs involved in DNA damage response WP1545,0.17354122762308447,2.1323148513982177,3.734408472316935,"['CDKN1A', 'CDKN1B', 'CCND1', 'H2AFX']",0.9999950490537614,0,0,4
89,Tryptophan catabolism leading to NAD+ production WP4210,0.17354122762308447,2.1323148513982177,3.734408472316935,"['NMNAT1', 'TDO2', 'HAAO', 'KMO']",0.9999950490537614,0,0,4
90,Blood Clotting Cascade WP272,0.1923148827436135,2.3984992101105846,3.9542167323645225,"['F8A1', 'F10', 'F5']",0.9999950490537614,0,0,3
91,EDA signaling in hair follicle development WP3930,0.1923148827436135,2.3984992101105846,3.9542167323645225,"['SOSTDC1', 'LTB', 'DKK1']",0.9999950490537614,0,0,3
92,"Metabolic pathway of LDL, HDL and TG, including diseases WP4522",0.1923148827436135,2.3984992101105846,3.9542167323645225,"['ANXA2', 'LDLRAP1', 'LDLR']",0.9999950490537614,0,0,3
93,Osteoclast Signaling WP12,0.1923148827436135,2.3984992101105846,3.9542167323645225,"['AIMP2', 'ATP6V1G1', 'SPP1']",0.9999950490537614,0,0,3
94,Breast cancer pathway WP4262,0.20576904286216957,1.2393468737554758,1.9594085108068255,"['SHC4', 'JUN', 'CDKN1A', 'SHC3', 'GADD45B', 'GADD45A', 'EGF', 'NOTCH4', 'TCF7', 'BRCA1', 'FGF1', 'WNT16', 'GADD45G', 'DLL3', 'FGF17', 'SFRP4', 'FRAT1', 'FRAT2', 'CCND1', 'HEY1', 'CSNK2B', 'BAX', 'HRAS', 'SKP1']",0.9999950490537614,0,0,24
95,ACE Inhibitor Pathway WP554,0.20775156370611544,3.1975259902618767,5.024631729534706,"['TGFB1', 'ATP6AP2']",0.9999950490537614,0,0,2
96,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.20775156370611544,3.1975259902618767,5.024631729534706,"['COX8A', 'GSTP1']",0.9999950490537614,0,0,2
97,LncRNA-mediated mechanisms of therapeutic resistance WP3672,0.20775156370611544,3.1975259902618767,5.024631729534706,"['CDKN1A', 'ABCB1']",0.9999950490537614,0,0,2
98,Metabolism of alpha-linolenic acid WP4586,0.20775156370611544,3.1975259902618767,5.024631729534706,"['ALOX5', 'ALOX12']",0.9999950490537614,0,0,2
99,miR-517 relationship with ARCN1 and USP1 WP3596,0.20775156370611544,3.1975259902618767,5.024631729534706,"['CDKN1A', 'ID2']",0.9999950490537614,0,0,2
100,DNA damage response WP707,0.2113564517163376,1.3713832738803011,2.1314165369437275,"['CDKN1A', 'CDKN1B', 'CASP8', 'CCND1', 'GADD45B', 'CDK5', 'GADD45A', 'H2AFX', 'CYCS', 'BAX', 'BRCA1', 'GADD45G']",0.9999950490537614,0,0,12
101,ERK Pathway in Huntington's Disease WP3853,0.21171332505648519,1.9189253259581194,2.979174091381955,"['CASP7', 'RPS6KA5', 'EGF', 'HRAS']",0.9999950490537614,0,0,4
102,GDNF/RET signaling axis WP4830,0.21171332505648519,1.9189253259581194,2.979174091381955,"['SALL1', 'SPRY1', 'SLIT2', 'GLI3']",0.9999950490537614,0,0,4
103,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.21995306845405013,1.7134387351778657,2.594730665763774,"['H3F3B', 'H2AFZ', 'H3F3A', 'H2AFX', 'PCGF1']",0.9999950490537614,0,0,5
104,Statin inhibition of cholesterol production WP430,0.21995306845405013,1.7134387351778657,2.594730665763774,"['SQLE', 'ABCG5', 'HMGCR', 'LDLR', 'FDFT1']",0.9999950490537614,0,0,5
105,Metabolic reprogramming in colon cancer WP4290,0.22035386588083852,1.4396674584323041,2.177526606793476,"['LDHA', 'PKM', 'MDH2', 'PGAM1', 'PGK1', 'PYCR1', 'ENO1', 'SLC16A3', 'GAPDH']",0.9999950490537614,0,0,9
106,Bladder cancer WP2828,0.22242084239885201,1.4764847341024627,2.219428236187275,"['CDKN1A', 'RPS6KA5', 'CCND1', 'EGF', 'DAPK2', 'HRAS', 'TYMP', 'VEGFA']",0.9999950490537614,0,0,8
107,Photodynamic therapy-induced unfolded protein response WP3613,0.22309506612337862,1.5993146171082113,2.399223486461881,"['PPP1R15A', 'XBP1', 'HSPA5', 'DDIT3', 'DNAJB9', 'CALR']",0.9999950490537614,0,0,6
108,Myometrial relaxation and contraction pathways WP289,0.2393573209203495,1.200398406374502,1.7163269728738015,"['YWHAB', 'RGS16', 'ACTB', 'ACTG1', 'RGS4', 'RGS5', 'RGS2', 'GNG3', 'GNG4', 'IGFBP6', 'YWHAG', 'CORIN', 'YWHAH', 'JUN', 'PRKCH', 'IGFBP5', 'IGFBP3', 'PRKCD', 'PRKAR1A', 'MAFF', 'CRH', 'CALM3', 'ATF5', 'CALM1', 'CALM2']",0.9999950490537614,0,0,25
109,Prader-Willi and Angelman Syndrome WP3998,0.23963583494549606,1.3710891089108912,1.9587857004222577,"['GABRR2', 'MAGEL2', 'CDKN2C', 'CCND1', 'DLX5', 'SNURF', 'NDN', 'GNRH1', 'ATP10A', 'TYR']",0.9999950490537614,0,0,10
110,Mevalonate arm of cholesterol biosynthesis pathway WP4190,0.24146281849341528,2.0556872037914693,2.9212132886022832,"['IDI1', 'HMGCS1', 'HMGCR']",0.9999950490537614,0,0,3
111,Nanoparticle triggered regulated necrosis WP2513,0.24146281849341528,2.0556872037914693,2.9212132886022832,"['CASP8', 'TRADD', 'FADD']",0.9999950490537614,0,0,3
112,miRNA regulation of DNA damage response WP1530,0.25080810327906733,1.308831477678089,1.8102018360860692,"['CDKN1A', 'CDKN1B', 'CASP8', 'CCND1', 'GADD45B', 'CDK5', 'GADD45A', 'H2AFX', 'CYCS', 'BAX', 'BRCA1', 'GADD45G']",0.9999950490537614,0,0,12
113,Eicosanoid Synthesis WP167,0.25191579595838065,1.7443338960525843,2.4048440499998534,"['PTGES2', 'ALOX5', 'ALOX12', 'PTGDS']",0.9999950490537614,0,0,4
114,Hematopoietic Stem Cell Differentiation WP2849,0.2538182828165799,1.5150152962477368,2.0772930585692193,"['CIITA', 'SPI1', 'IL5', 'MYB', 'PIM1', 'RUNX1']",0.9999950490537614,0,0,6
115,Striated Muscle Contraction Pathway WP383,0.25458524863351484,1.5990777338603426,2.1877294839487926,"['MYOM1', 'TNNT2', 'TCAP', 'VIM', 'ACTG1']",0.9999950490537614,0,0,5
116,Translation Factors WP107,0.2565122863322087,1.319651347068146,1.7954895348177404,"['EIF4A2', 'EEF1B2', 'EIF5A', 'EEF1G', 'EEF1A1', 'EIF1AX', 'EIF3I', 'EEF1A2', 'EIF4H', 'EEF2', 'EIF1']",0.9999950490537614,0,0,11
117,Ferroptosis WP4313,0.27419317190144715,1.370795409576573,1.773702905535008,"['PRNP', 'MAP1LC3B', 'MAP1LC3A', 'GPX4', 'PCBP1', 'ACSL5', 'SLC39A8', 'CP']",0.9999950490537614,0,0,8
118,Glycogen Synthesis and Degradation WP500,0.27419317190144715,1.370795409576573,1.773702905535008,"['GYS2', 'GSK3A', 'PHKG1', 'PPP2R1A', 'CALM3', 'GYG2', 'CALM1', 'CALM2']",0.9999950490537614,0,0,8
119,Biogenic Amine Synthesis WP550,0.27757089766756204,2.3979470983024083,3.073398178436055,"['GAD1', 'PAH']",0.9999950490537614,0,0,2
120,Cellular Proteostasis WP4918,0.27757089766756204,2.3979470983024083,3.073398178436055,"['VBP1', 'PFDN6']",0.9999950490537614,0,0,2
121,Development of pulmonary dendritic cells and macrophage subsets WP3892,0.27757089766756204,2.3979470983024083,3.073398178436055,"['SPI1', 'ID2']",0.9999950490537614,0,0,2
122,Irinotecan pathway WP229,0.27757089766756204,2.3979470983024083,3.073398178436055,"['ABCC2', 'CYP3A5']",0.9999950490537614,0,0,2
123,Methylation Pathways WP704,0.27757089766756204,2.3979470983024083,3.073398178436055,"['NNMT', 'MAT2B']",0.9999950490537614,0,0,2
124,Peroxiredoxin 2 induced ovarian failure WP4873,0.27757089766756204,2.3979470983024083,3.073398178436055,"['PRDX2', 'BAX']",0.9999950490537614,0,0,2
125,Genes controlling nephrogenesis WP4823,0.28559812367053755,1.4391459074733095,1.8034939275741382,"['CXCL12', 'LAMB2', 'SLIT2', 'ETV4', 'GLI3', 'VEGFA']",0.9999950490537614,0,0,6
126,Oxysterols derived from cholesterol WP4545,0.28559812367053755,1.4391459074733095,1.8034939275741382,"['CYP39A1', 'DBP', 'INSIG1', 'ACOT11', 'DHCR7', 'ACOT6']",0.9999950490537614,0,0,6
127,Endochondral Ossification with Skeletal Dysplasias WP4808,0.2856949735332885,1.2967621086432968,1.6246232031846564,"['CDKN1C', 'GHR', 'ADAMTS5', 'TGFB1', 'HMGCS1', 'SPP1', 'CALM1', 'CALM2', 'GLI3', 'VEGFA']",0.9999950490537614,0,0,10
128,Endochondral Ossification WP474,0.2856949735332885,1.2967621086432968,1.6246232031846564,"['CDKN1C', 'GHR', 'ADAMTS5', 'TGFB1', 'HMGCS1', 'SPP1', 'CALM1', 'CALM2', 'GLI3', 'VEGFA']",0.9999950490537614,0,0,10
129,Heart Development WP1591,0.2904080829862532,1.4990118577075098,1.8534804371816003,"['BMP2', 'HEY1', 'VEGFB', 'VEGFC', 'VEGFA']",0.9999950490537614,0,0,5
130,Cancer immunotherapy by PD-1 blockade WP4585,0.2922993097965743,1.7985781990521328,2.212209760254624,"['JUN', 'HLA-A', 'PDCD1LG2']",0.9999950490537614,0,0,3
131,Cysteine and methionine catabolism WP4504,0.2922993097965743,1.7985781990521328,2.212209760254624,"['MPST', 'AHCY', 'GOT1']",0.9999950490537614,0,0,3
132,Glutathione metabolism WP100,0.2922993097965743,1.7985781990521328,2.212209760254624,"['GPX2', 'GSTM2', 'GPX4']",0.9999950490537614,0,0,3
133,Inflammatory Response Pathway WP453,0.2922993097965743,1.7985781990521328,2.212209760254624,"['IL5', 'LAMB2', 'FN1']",0.9999950490537614,0,0,3
134,"GPCRs, Other WP117",0.29329212189511383,1.3084646944504428,1.6049446897556865,"['ADGRE2', 'HTR7', 'ADGRV1', 'ADORA2A', 'HTR1F', 'GNRHR', 'ADRA1D', 'MCHR2', 'NTSR1']",0.9999950490537614,0,0,9
135,Nephrotic syndrome WP4758,0.3012350093831026,1.3234174365132432,1.587921675922432,"['CUBN', 'MYO1E', 'INF2', 'ITGB4', 'LAMB2', 'PMM2', 'GPC5', 'EMP2']",0.9999950490537614,0,0,8
136,Development of ureteric collection system WP5053,0.30953023465716717,1.3431803797468354,1.5751469636531168,"['SALL1', 'CCND1', 'SPRY1', 'SLIT2', 'ETV4', 'GLI3', 'GLI2']",0.9999950490537614,0,0,7
137,Synaptic Vesicle Pathway WP2267,0.3096011938397845,1.2625325690463782,1.4802819162569252,"['RAB3A', 'SLC32A1', 'PARK7', 'SYN3', 'SLC25A4', 'CPLX1', 'SLC18A2', 'AP2M1', 'VAMP2', 'CPLX3']",0.9999950490537614,0,0,10
138,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.31428476408097,1.2249854529815063,1.4178665322599693,"['CDKN1C', 'MYO1E', 'CDKN1A', 'CDKN1B', 'INF2', 'PCNA', 'TGFB1', 'ITGB4', 'LAMB2', 'FAT1', 'VIM', 'DKK1']",0.9999950490537614,0,0,12
139,COVID-19 adverse outcome pathway WP4891,0.31542125663165327,4.795185477505919,5.53290659395467,['IL7'],0.9999950490537614,0,0,1
140,7-oxo-C and 7beta-HC pathways WP5064,0.32702605034751175,1.4107184375726576,1.5767817884595514,"['HSD11B1', 'DBP', 'ACOT11', 'DHCR7', 'ACOT6']",0.9999950490537614,0,0,5
141,Small cell lung cancer WP4658,0.3274031601128152,1.1652899126290708,1.3011195563697784,"['CDKN1C', 'CDKN1A', 'CDKN1B', 'LAMB3', 'GADD45B', 'LAMB2', 'GADD45A', 'LAMB4', 'FN1', 'CKS1B', 'GADD45G', 'CASP8', 'CCND1', 'CKS2', 'CYCS', 'BAX', 'SKP1']",0.9999950490537614,0,0,17
142,Calcium Regulation in the Cardiac Cell WP536,0.3315456955328145,1.1291493897439502,1.2465692216405289,"['KCNJ5', 'PRKCH', 'YWHAB', 'RGS16', 'CHRM5', 'PRKCD', 'ADRA1D', 'ATP1B1', 'RGS4', 'GJD2', 'RGS5', 'RGS2', 'GNG3', 'PLN', 'PRKAR1A', 'GNG4', 'GJA9', 'CALM3', 'CALR', 'CASQ1', 'CALM1', 'CALM2', 'YWHAG', 'YWHAH']",0.9999950490537614,0,0,24
143,Constitutive Androstane Receptor Pathway WP2875,0.33585094698674034,1.475731696197915,1.6101528905273177,"['HSP90AA1', 'ABCB1', 'ABCC2', 'CYP3A5']",0.9999950490537614,0,0,4
144,"GPCRs, Class B Secretin-like WP334",0.33585094698674034,1.475731696197915,1.6101528905273177,"['ADGRE2', 'VIPR1', 'CALCR', 'ADGRG2']",0.9999950490537614,0,0,4
145,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.33585094698674034,1.475731696197915,1.6101528905273177,"['GSK3A', 'ITGB4', 'BAX', 'BCL2L14']",0.9999950490537614,0,0,4
146,Biomarkers for pyrimidine metabolism disorders WP4584,0.3437131242852081,1.5986045286993154,1.707226366239987,"['NT5C', 'CKB', 'TYMP']",0.9999950490537614,0,0,3
147,Genes targeted by miRNAs in adipocytes WP1992,0.3437131242852081,1.5986045286993154,1.707226366239987,"['KCNE1', 'TMSB4X', 'KCNQ1']",0.9999950490537614,0,0,3
148,IL1 and megakaryocytes in obesity WP2865,0.3437131242852081,1.5986045286993154,1.707226366239987,"['IL1R1', 'IL18', 'TIMP2']",0.9999950490537614,0,0,3
149,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.34491123674525775,1.2334916864608076,1.3130126503477124,"['JUN', 'CD4', 'IL5', 'AHSA1', 'LCP2', 'PTPN6', 'CALM1', 'CALM2', 'CARD11']",0.9999950490537614,0,0,9
150,Ketogenesis and Ketolysis WP4742,0.3468984908764859,1.9181997631267271,2.0308423523123253,"['CPT2', 'BDH1']",0.9999950490537614,0,0,2
151,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.3468984908764859,1.9181997631267271,2.0308423523123253,"['CHI3L1', 'BAX']",0.9999950490537614,0,0,2
152,Methionine metabolism leading to sulfur amino acids and related disorders WP4292,0.3468984908764859,1.9181997631267271,2.0308423523123253,"['AHCY', 'MAT2B']",0.9999950490537614,0,0,2
153,Role of Osx and miRNAs in tooth development WP3971,0.3468984908764859,1.9181997631267271,2.0308423523123253,"['NOTCH4', 'DKK1']",0.9999950490537614,0,0,2
154,Sulfation Biotransformation Reaction WP692,0.3468984908764859,1.9181997631267271,2.0308423523123253,"['SULT4A1', 'PAPSS2']",0.9999950490537614,0,0,2
155,Metapathway biotransformation Phase I and II WP702,0.36149283640898255,1.1253851891106792,1.1450941205584897,"['CHST9', 'GSTM2', 'GPX2', 'NNMT', 'GPX4', 'GSTP1', 'KCNAB1', 'GLYAT', 'CYP2C18', 'CYP3A5', 'FMO5', 'CYP3A7', 'CYP39A1', 'CYP26A1', 'GAL3ST2', 'NAT8L', 'SULT4A1', 'CHST2', 'GSTM5']",0.9999950490537614,0,0,19
156,DNA Mismatch Repair WP531,0.364060179737869,1.3322353974527887,1.3461387340358464,"['PCNA', 'POLD1', 'RPA3', 'POLE2', 'POLE3']",0.9999950490537614,0,0,5
157,7q11.23 copy number variation syndrome WP4932,0.36418464249419025,1.132733209778484,1.1441673363695206,"['CDKN1C', 'PCNA', 'H2AFX', 'HMGA1', 'ATP5MC3', 'UBE2L6', 'ACACB', 'ATP5F1D', 'ATP5F1E', 'ATP5MC1', 'CLDN5', 'ATP5F1B', 'CFL1', 'EIF4H', 'GTF2IRD1', 'GAPDH', 'VAMP2']",0.9999950490537614,0,0,17
158,16p11.2 proximal deletion syndrome WP4949,0.3689010970135682,1.1548300878197786,1.1516273982780945,"['PCNA', 'IGFBP3', 'GDPD3', 'SEZ6L2', 'CCT6B', 'CASP8', 'PPP2R1A', 'TCP1', 'KCTD13', 'ALDOA', 'CCT7', 'CDIPT', 'YPEL3']",0.9999950490537614,0,0,13
159,DNA Replication WP466,0.36992621565415096,1.2434804266291608,1.236581237086732,"['PCNA', 'POLD1', 'RPA3', 'POLE2', 'GMNN', 'UBC', 'UBA52']",0.9999950490537614,0,0,7
160,Methionine De Novo and Salvage Pathway WP3580,0.37840464102702703,1.3702094033978665,1.331557408876878,"['AHCY', 'CHDH', 'ODC1', 'MAT2B']",0.9999950490537614,0,0,4
161,Nucleotide metabolism WP404,0.37840464102702703,1.3702094033978665,1.331557408876878,"['PRPS1', 'POLD1', 'NME2', 'OAZ1']",0.9999950490537614,0,0,4
162,Purinergic signaling WP4900,0.37840464102702703,1.3702094033978665,1.331557408876878,"['P2RY12', 'ADORA2A', 'LPAR6', 'P2RY14']",0.9999950490537614,0,0,4
163,Differentiation Pathway WP2848,0.3845323989109138,1.2511217700758162,1.1957311451325459,"['TGFB1', 'EGF', 'FST', 'FGF1', 'DKK1', 'VEGFA']",0.9999950490537614,0,0,6
164,Acute viral myocarditis WP4298,0.3942584382510709,1.1469544546268862,1.067526310333362,"['CASP7', 'CD4', 'CASP8', 'ENDOG', 'TGFB1', 'CCND1', 'CYCS', 'BAX', 'ACTB', 'SGCG', 'EIF4G2']",0.9999950490537614,0,0,11
165,H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity WP3969,0.39476467843379265,1.4386255924170617,1.3371527727205181,"['CCND1', 'TULP3', 'SOX4']",0.9999950490537614,0,0,3
166,Matrix Metalloproteinases WP129,0.39476467843379265,1.4386255924170617,1.3371527727205181,"['MMP25', 'TIMP2', 'MMP21']",0.9999950490537614,0,0,3
167,Vitamin B12 metabolism WP1533,0.4011562514356447,1.2620137299771168,1.152728733694899,"['SERPINA3', 'CUBN', 'LRP2', 'LDLR', 'SOD1']",0.9999950490537614,0,0,5
168,Biomarkers for urea cycle disorders WP4583,0.4138246487305235,1.5983682063429399,1.4102609652021298,"['F10', 'GOT1']",0.9999950490537614,0,0,2
169,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.42065837961500524,1.2787567496378243,1.1073192343844076,"['CASP7', 'CASP8', 'BAX', 'FADD']",0.9999950490537614,0,0,4
170,Kallmann's Syndrome WP5074,0.42065837961500524,1.2787567496378243,1.1073192343844076,"['PLXND1', 'TMEM98', 'GNRH1', 'ASCL1']",0.9999950490537614,0,0,4
171,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.42065837961500524,1.2787567496378243,1.1073192343844076,"['JUN', 'ABCC2', 'SRXN1', 'GSTP1']",0.9999950490537614,0,0,4
172,VEGFA-VEGFR2 Signaling Pathway WP3888,0.4257973497957905,1.0336122301145987,0.8824895953920051,"['TRAF3IP2', 'HSPB1', 'RPL10A', 'ETS1', 'RPL7', 'ACTG1', 'TUBB8', 'RPS6KA5', 'RPL18A', 'CCND1', 'TMSB4X', 'CFL1', 'RPLP2', 'SH3BGRL3', 'CHAC1', 'ATP6V1E1', 'IER5', 'HRAS', 'DUSP5', 'HSP90AA1', 'SSR4', 'TRPC3', 'IGFBP3', 'PRKCD', 'GAB1', 'RPL13A', 'DKK1', 'TXNIP', 'RPL27', 'RPL26', 'ALDOA', 'GAPDH', 'SLC25A11', 'FJX1', 'ARF6', 'KANK1', 'SET', 'EPB41', 'NOTCH4', 'FOXO4', 'ACACB', 'APOLD1', 'PRDX2', 'STIP1', 'LDHA', 'DNAJB4', 'PGK1', 'DNAJB9', 'MYH11', 'FADD', 'CCT7', 'SLC25A25', 'JUN', 'SDF2L1', 'FN1', 'BMX', 'VEGFA', 'DNAJA1', 'NR4A1', 'BMP2', 'NR4A3', 'CYCS', 'HYOU1', 'PTPN6', 'CALR', 'EIF4G2', 'HSPA1A']",0.9999950490537614,0,0,67
173,Adipogenesis WP236,0.4265928081734915,1.0791418355184743,0.919348266029209,"['GDF10', 'CDKN1A', 'CEBPB', 'TGFB1', 'GADD45B', 'GADD45A', 'ASIP', 'EBF1', 'HMGA1', 'MIF', 'PRLR', 'SFRP4', 'CYP26A1', 'BMP2', 'DDIT3', 'NDN', 'ID3', 'PCK2']",0.9999950490537614,0,0,18
174,Folate Metabolism WP176,0.4309139644884524,1.1575321911828895,0.9744648024840867,"['SERPINA3', 'GPX2', 'AHCY', 'GPX4', 'RFK', 'LDLR', 'SOD1']",0.9999950490537614,0,0,7
175,G13 Signaling Pathway WP524,0.4309139644884524,1.1575321911828895,0.9744648024840867,"['CFL2', 'CFL1', 'ARHGDIG', 'WAS', 'IQGAP2', 'CALM1', 'CALM2']",0.9999950490537614,0,0,7
176,Hepatitis C and Hepatocellular Carcinoma WP3646,0.4309139644884524,1.1575321911828895,0.9744648024840867,"['CDKN1A', 'CASP7', 'JUN', 'TGFB1', 'CCND1', 'BRCA1', 'VEGFA']",0.9999950490537614,0,0,7
177,SARS-CoV-2 altering angiogenesis via NRP1 WP5065,0.4335965826167645,2.3973954222573006,2.003361213541026,['VEGFA'],0.9999950490537614,0,0,1
178,Differentiation of white and brown adipocyte WP2895,0.4446877554558942,1.3077337354588539,1.0597650782020334,"['CEBPB', 'BMP2', 'ZIC1']",0.9999950490537614,0,0,3
179,Fatty acid transporters WP5061,0.4446877554558942,1.3077337354588539,1.0597650782020334,"['FABP6', 'ACSL5', 'ACSBG2']",0.9999950490537614,0,0,3
180,TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition WP3859,0.4446877554558942,1.3077337354588539,1.0597650782020334,"['TGFB1', 'FN1', 'VIM']",0.9999950490537614,0,0,3
181,TP53 network WP1742,0.4446877554558942,1.3077337354588539,1.0597650782020334,"['CDKN1A', 'GADD45A', 'BAX']",0.9999950490537614,0,0,3
182,Androgen receptor signaling pathway WP138,0.44710201510965625,1.0736496090973704,0.8642541032127352,"['CDKN1A', 'JUN', 'RNF6', 'BRCA1', 'PARK7', 'ETV5', 'RHOB', 'CCND1', 'KAT5', 'PRDX1', 'BAG1', 'STUB1', 'CALR', 'FKBP4', 'RAN']",0.9999950490537614,0,0,15
183,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.4507060598440941,1.106614288324502,0.8819050846700313,"['BEX3', 'CDKN1A', 'CASP7', 'CDKN1B', 'HSPA5', 'HSPB1', 'VIM', 'YBX3', 'ETS1']",0.9999950490537614,0,0,9
184,Alpha 6 Beta 4 signaling pathway WP244,0.4509063142088503,1.1508422301304864,0.9166408762668122,"['LAMB3', 'ITGB4', 'LAMB2', 'PRKCD', 'GAB1', 'HRAS']",0.9999950490537614,0,0,6
185,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.45856729539081414,1.0898289828982899,0.849683232201484,"['CDKN1A', 'JUN', 'CDKN1B', 'TMSB4X', 'FN1', 'PFN4', 'WNT16', 'NEFH', 'PFN2', 'SOD1']",0.9999950490537614,0,0,10
186,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.4621766453810544,1.1987356775977875,0.9251939197153621,"['GOT1', 'MDH2', 'SCO2', 'HMGA1']",0.9999950490537614,0,0,4
187,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.4621766453810544,1.1987356775977875,0.9251939197153621,"['GSK3A', 'PTPN6', 'CALM1', 'CALM2']",0.9999950490537614,0,0,4
188,Urea cycle and associated pathways WP4595,0.4621766453810544,1.1987356775977875,0.9251939197153621,"['SLC25A15', 'GOT1', 'MDH2', 'PYCR1']",0.9999950490537614,0,0,4
189,Endothelin Pathways WP2197,0.4742746693186083,1.1416337285902503,0.8516229758538655,"['ADCY10', 'NPY', 'NPY1R', 'CALM1', 'CALM2']",0.9999950490537614,0,0,5
190,Tryptophan metabolism WP465,0.4742746693186083,1.1416337285902503,0.8516229758538655,"['TDO2', 'HAAO', 'ALDH1A2', 'CYP2C18', 'ACMSD']",0.9999950490537614,0,0,5
191,Endometrial cancer WP4155,0.4890274409111562,1.0548494453248811,0.7545724945267828,"['CDKN1A', 'CCND1', 'GADD45B', 'EGF', 'GADD45A', 'TCF7', 'BAX', 'CTNNA3', 'FGF1', 'HRAS', 'GADD45G']",0.9999950490537614,0,0,11
192,Eicosanoid metabolism via lipooxygenases (LOX) WP4721,0.49288072221421936,1.198657187993681,0.8480356688951003,"['HPGD', 'ALOX5', 'ALOX12']",0.9999950490537614,0,0,3
193,Microglia Pathogen Phagocytosis Pathway WP3937,0.5025927582113359,1.1281288493271666,0.7761245157691989,"['C1QB', 'C1QA', 'HCK', 'PTPN6']",0.9999950490537614,0,0,4
194,PI3K-Akt signaling pathway WP4172,0.5088643555597893,1.008033639709662,0.6810011063968304,"['CDKN1A', 'CDKN1B', 'HSP90AB1', 'ITGB4', 'BRCA1', 'FGF1', 'GYS2', 'GHR', 'GNG3', 'RELN', 'CCND1', 'PPP2R1A', 'GNG4', 'PDGFD', 'MYB', 'NTF3', 'SPP1', 'HRAS', 'PCK2', 'HSP90AA1', 'ANGPT2', 'ANGPT1', 'LAMB3', 'EGF', 'LAMB2', 'LAMB4', 'FN1', 'VEGFB', 'VEGFC', 'PRLR', 'EPOR', 'VEGFA', 'FGF17', 'EFNA3', 'LPAR6', 'IL7', 'DDIT4', 'IL3RA', 'ITGA5', 'FGFR4', 'SGK2']",0.9999950490537614,0,0,41
195,Cardiac Progenitor Differentiation WP2406,0.5097558521426807,1.0896514552641035,0.7342326366068873,"['MESP1', 'TGFB1', 'TNNT2', 'THY1', 'DKK1']",0.9999950490537614,0,0,5
196,Oxidation by Cytochrome P450 WP43,0.5097558521426807,1.0896514552641035,0.7342326366068873,"['CYP39A1', 'CYP26A1', 'CYP3A5', 'CYP2C18', 'CYP3A7']",0.9999950490537614,0,0,5
197,Pre-implantation embryo WP3527,0.5097558521426807,1.0896514552641035,0.7342326366068873,"['ZFP36', 'DLX2', 'DDIT3', 'HMGA1', 'HNRNPAB']",0.9999950490537614,0,0,5
198,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.5123065698848626,1.0340806687175663,0.6916263078220491,"['SFRP4', 'FRAT1', 'JUN', 'FRAT2', 'CCND1', 'CSNK2B', 'TCF7', 'NOTUM', 'WNT16', 'DKK1', 'CXXC4']",0.9999950490537614,0,0,11
199,Parkinson's disease pathway WP2371,0.5155257746542267,1.0654189183252054,0.7059124578472239,"['CASP7', 'PINK1', 'UBB', 'CYCS', 'UBE2L6', 'PARK7']",0.9999950490537614,0,0,6
200,Apoptosis Modulation and Signaling WP1772,0.5163588288642887,1.0273483947681332,0.6790293635569263,"['CASP7', 'JUN', 'CASP8', 'ENDOG', 'IL1R1', 'TRADD', 'PEA15', 'CYCS', 'BAX', 'FADD', 'PTPN13', 'HSPA1A']",0.9999950490537614,0,0,12
201,G1 to S cell cycle control WP45,0.5285440307832387,1.0273159144893111,0.6550465881325694,"['CDKN1C', 'CDKN1A', 'CDKN1B', 'PCNA', 'CDKN2C', 'CCND1', 'GADD45A', 'RPA3', 'POLE2']",0.9999950490537614,0,0,9
202,Composition of Lipid Particles WP3601,0.531378530812985,1.598132070507761,1.0104679805748842,['LDLR'],0.9999950490537614,0,0,1
203,Platelet-mediated interactions with vascular and circulating cells WP4462,0.531378530812985,1.598132070507761,1.0104679805748842,['TGFB1'],0.9999950490537614,0,0,1
204,Synthesis and Degradation of Ketone Bodies WP311,0.531378530812985,1.598132070507761,1.0104679805748842,['BDH1'],0.9999950490537614,0,0,1
205,Vitamin B6-dependent and responsive disorders WP4228,0.531378530812985,1.598132070507761,1.0104679805748842,['PNPO'],0.9999950490537614,0,0,1
206,Proteasome Degradation WP183,0.5320437106954212,1.0200126395618285,0.6436581985934778,"['PSMD8', 'PSMB6', 'UBB', 'H2AFZ', 'H2AFX', 'UBC', 'HLA-B', 'HLA-A', 'PSMB10', 'HLA-E']",0.9999950490537614,0,0,10
207,Melanoma WP4685,0.5352723100659306,1.0141106912105327,0.6337985659480847,"['CDKN1A', 'CCND1', 'GADD45B', 'GADD45A', 'BAX', 'CALM3', 'CALM1', 'ETS1', 'HRAS', 'CALM2', 'GADD45G']",0.9999950490537614,0,0,11
208,Amplification and Expansion of Oncogenic Pathways as Metastatic Traits WP3678,0.5360256656323291,1.1985787603632057,0.7474016354997616,"['TCF7', 'VEGFA']",0.9999950490537614,0,0,2
209,Dopamine metabolism WP2436,0.5360256656323291,1.1985787603632057,0.7474016354997616,"['TYR', 'SOD1']",0.9999950490537614,0,0,2
210,miR-509-3p alteration of YAP1/ECM axis WP3967,0.5360256656323291,1.1985787603632057,0.7474016354997616,"['YAP1', 'FN1']",0.9999950490537614,0,0,2
211,Simplified Depiction of MYD88 Distinct Input-Output Pathway WP3877,0.5360256656323291,1.1985787603632057,0.7474016354997616,"['JUN', 'TIFA']",0.9999950490537614,0,0,2
212,Transcriptional cascade regulating adipogenesis WP4211,0.5360256656323291,1.1985787603632057,0.7474016354997616,"['CEBPB', 'DDIT3']",0.9999950490537614,0,0,2
213,Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway WP3670,0.5388916418140843,1.1063616478308422,0.6839978702812527,"['BMP2', 'TGFB1', 'FN1']",0.9999950490537614,0,0,3
214,SREBF and miR33 in cholesterol and lipid homeostasis WP2011,0.5388916418140843,1.1063616478308422,0.6839978702812527,"['HMGCS1', 'HMGCR', 'LDLR']",0.9999950490537614,0,0,3
215,Urea cycle and metabolism of amino groups WP497,0.5388916418140843,1.1063616478308422,0.6839978702812527,"['ODC1', 'PYCR1', 'CKB']",0.9999950490537614,0,0,3
216,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817,0.5416075604358922,1.065367224197726,0.6532976687795057,"['CEBPB', 'CCND1', 'ATP2C2', 'PRLR']",0.9999950490537614,0,0,4
217,IL-3 signaling pathway WP286,0.5491292569815396,1.016889624088991,0.6095454269458868,"['HCK', 'JUN', 'TGFB1', 'YWHAB', 'IL3RA', 'PTPN6', 'HRAS']",0.9999950490537614,0,0,7
218,TGF-beta Receptor Signaling WP560,0.5491292569815396,1.016889624088991,0.6095454269458868,"['JUN', 'TGFB1', 'EGF', 'FST', 'SPP1', 'HRAS', 'LTBP1']",0.9999950490537614,0,0,7
219,Modulators of TCR signaling and T cell activation WP5072,0.5514368509301929,1.0092266677774768,0.6007199216072624,"['CDKN1B', 'NDUFB10', 'ELOB', 'LCP2', 'PTPN6', 'CD247', 'CARD11', 'ZFP36L1']",0.9999950490537614,0,0,8
220,Prion disease pathway WP3995,0.5774875857941827,0.9986824769433466,0.5483449230887589,"['PRNP', 'SPI1', 'HSPA5', 'RFX5', 'EBF1']",0.9999950490537614,0,0,5
221,Genotoxicity pathway WP4286,0.5775266712619361,0.9832678863149777,0.5398147122992727,"['PLK3', 'BTG2', 'CDKN1A', 'RPS27', 'GADD45A', 'ID2', 'TRIAP1', 'PHLDA3']",0.9999950490537614,0,0,8
222,Nicotine Activity on Dopaminergic Neurons WP1602,0.5824003330713764,1.0272511848341233,0.5553291247014065,"['CHRNB2', 'CDK5', 'SLC18A2']",0.9999950490537614,0,0,3
223,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.5824003330713764,1.0272511848341233,0.5553291247014065,"['EIF1AX', 'EIF3I', 'EIF1']",0.9999950490537614,0,0,3
224,Alanine and aspartate metabolism WP106,0.5901870395640191,1.0653156117032943,0.5617577285886912,"['GOT1', 'GAD1']",0.9999950490537614,0,0,2
225,Ganglio Sphingolipid Metabolism WP1423,0.5901870395640191,1.0653156117032943,0.5617577285886912,"['B3GALT1', 'ST3GAL1']",0.9999950490537614,0,0,2
226,Mammary gland development pathway - Embryonic development (Stage 1 of 4) WP2813,0.5901870395640191,1.0653156117032943,0.5617577285886912,"['TGFB1', 'CCND1']",0.9999950490537614,0,0,2
227,RalA downstream regulated genes WP2290,0.5901870395640191,1.0653156117032943,0.5617577285886912,"['YBX3', 'HRAS']",0.9999950490537614,0,0,2
228,Alzheimer's disease WP2059,0.6017767713739831,0.9585414189456996,0.4868131978631292,"['PSENEN', 'ATP5MD', 'CASP7', 'CASP8', 'CDK5', 'CYCS', 'CALM3', 'FADD', 'CALM1', 'GAPDH', 'CALM2', 'CDK5R1']",0.9999950490537614,0,0,12
229,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.6028907779693883,0.9586070439256035,0.4850735979747916,"['CDKN1A', 'CEBPB', 'BMP2', 'TGFB1', 'MSTN', 'TCF7', 'SPP1', 'ACTB']",0.9999950490537614,0,0,8
230,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.6041666482807164,0.9586234177215189,0.4830553359152183,"['IDI1', 'SQLE', 'HMGCS1', 'MSMO1', 'HMGCR', 'DHCR7', 'FDFT1']",0.9999950490537614,0,0,7
231,Hedgehog Signaling Pathway WP4249,0.6062070412258017,0.9586397785686042,0.4798315144472385,"['EVC', 'CCND1', 'HHIP', 'LRP2', 'GLI3', 'GLI2']",0.9999950490537614,0,0,6
232,CAMKK2  Pathway WP4874,0.6094177147180483,0.9586561264822134,0.4747757348240034,"['FIS1', 'MAP1LC3A', 'WFS1', 'CALM1', 'CALM2']",0.9999950490537614,0,0,5
233,Eicosanoid metabolism via cytochrome P450 monooxygenases (CYP) pathway WP4720,0.6122852070566196,1.1985003946329913,0.5879328544772506,['CYP2C18'],0.9999950490537614,0,0,1
234,Mitochondrial fatty acid synthesis pathway WP4317,0.6122852070566196,1.1985003946329913,0.5879328544772506,['HSD17B12'],0.9999950490537614,0,0,1
235,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.6122852070566196,1.1985003946329913,0.5879328544772506,['DLL3'],0.9999950490537614,0,0,1
236,Tgif disruption of Shh signaling WP3674,0.6122852070566196,1.1985003946329913,0.5879328544772506,['GLI3'],0.9999950490537614,0,0,1
237,Vitamin D Metabolism WP1531,0.6122852070566196,1.1985003946329913,0.5879328544772506,['DHCR7'],0.9999950490537614,0,0,1
238,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.6227864150908556,0.9413629160063391,0.44578396390777786,"['CDKN1A', 'JUN', 'TGFB1', 'CCND1', 'GADD45B', 'GADD45A', 'TCF7', 'CYCS', 'BAX', 'NTN1', 'GADD45G']",0.9999950490537614,0,0,11
239,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.6303148104795349,0.9319180731364276,0.430113632847556,"['PPP1R15A', 'PPP1R14B', 'XBP1', 'MAP1LC3A', 'HSPA5', 'PPP1R1A', 'DDIT3']",0.9999950490537614,0,0,7
240,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.6342782465260832,0.9276393831553974,0.4223241057048212,"['CASP8', 'TGFB1', 'CXCL12', 'TRADD', 'CXCL17', 'FADD']",0.9999950490537614,0,0,6
241,FOXA2 pathway WP5066,0.6394817810937755,0.9587050927753652,0.42863431243398714,"['GSTM2', 'ABCC2']",0.9999950490537614,0,0,2
242,Hedgehog Signaling Pathway Netpath WP47,0.6394817810937755,0.9587050927753652,0.42863431243398714,"['GLI3', 'GLI2']",0.9999950490537614,0,0,2
243,Overview of nanoparticle effects WP3287,0.6394817810937755,0.9587050927753652,0.42863431243398714,"['FN1', 'BAX']",0.9999950490537614,0,0,2
244,Pathways in clear cell renal cell carcinoma WP4018,0.6417574711004085,0.9274673008323424,0.4113733147194056,"['LDHA', 'TPI1', 'PKM', 'TGFB1', 'PGK1', 'ALDOC', 'ENO1', 'ENO2', 'ALDOA', 'GAPDH', 'ACACB', 'VEGFA']",0.9999950490537614,0,0,12
245,Glycosylation and related congenital defects WP4521,0.6481825042179342,0.9129461345976557,0.39583790559275744,"['DPM3', 'MPI', 'PMM2', 'DOLK']",0.9999950490537614,0,0,4
246,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.6481825042179342,0.9129461345976557,0.39583790559275744,"['RAB3B', 'RAB3A', 'HSPB1', 'RABAC1']",0.9999950490537614,0,0,4
247,Oxidative Stress WP408,0.6481825042179342,0.9129461345976557,0.39583790559275744,"['NOX3', 'NOX5', 'TXN2', 'SOD1']",0.9999950490537614,0,0,4
248,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.6554572497595843,0.9066562606910709,0.3829917283529307,"['JUN', 'TGFB1', 'EGF', 'FST', 'SPP1', 'HRAS', 'LTBP1']",0.9999950490537614,0,0,7
249,Aryl Hydrocarbon Receptor Netpath WP2586,0.6611325314492013,0.8985765124555161,0.37183182150363975,"['CDKN1A', 'HSP90AA1', 'CDKN1B', 'AIP', 'HRAS', 'VEGFA']",0.9999950490537614,0,0,6
250,Integrated Cancer Pathway WP1971,0.6611325314492013,0.8985765124555161,0.37183182150363975,"['CDKN1A', 'CDKN1B', 'CASP8', 'BAX', 'BRCA1', 'BACH1']",0.9999950490537614,0,0,6
251,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.6611758557928193,0.898696682464455,0.37182265785737156,"['LDHA', 'ACACB', 'VEGFA']",0.9999950490537614,0,0,3
252,NAD+ biosynthetic pathways WP3645,0.6611758557928193,0.898696682464455,0.37182265785737156,"['NMNAT1', 'TDO2', 'ACMSD']",0.9999950490537614,0,0,3
253,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.6632474215795767,0.90875184436308,0.3731400262506414,"['SFRP4', 'FRAT1', 'JUN', 'FRAT2', 'CCND1', 'CSNK2B', 'TCF7', 'NOTUM', 'WNT16', 'DKK1', 'CXXC4']",0.9999950490537614,0,0,11
254,ApoE and miR-146 in inflammation and atherosclerosis WP3926,0.6792280018013568,0.9587213891081294,0.3708319158544167,['SPI1'],0.9999950490537614,0,0,1
255,Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism WP4523,0.6792280018013568,0.9587213891081294,0.3708319158544167,['HSD11B1'],0.9999950490537614,0,0,1
256,mir-124 predicted interactions with cell cycle and differentiation  WP3595,0.6792280018013568,0.9587213891081294,0.3708319158544167,['STRADB'],0.9999950490537614,0,0,1
257,miRNA Biogenesis WP2338,0.6792280018013568,0.9587213891081294,0.3708319158544167,['RAN'],0.9999950490537614,0,0,1
258,Osteoblast Signaling WP322,0.6792280018013568,0.9587213891081294,0.3708319158544167,['BGLAP'],0.9999950490537614,0,0,1
259,Small Ligand GPCRs WP247,0.6792280018013568,0.9587213891081294,0.3708319158544167,['S1PR3'],0.9999950490537614,0,0,1
260,Somatic sex determination WP4814,0.6792280018013568,0.9587213891081294,0.3708319158544167,['PTGDS'],0.9999950490537614,0,0,1
261,Tamoxifen metabolism WP691,0.6792280018013568,0.9587213891081294,0.3708319158544167,['CYP3A5'],0.9999950490537614,0,0,1
262,Urea cycle and related diseases WP4571,0.6792280018013568,0.9587213891081294,0.3708319158544167,['SLC25A15'],0.9999950490537614,0,0,1
263,Copper homeostasis WP3286,0.6795435339337068,0.8827240173217855,0.34102628271572594,"['PRNP', 'JUN', 'CCND1', 'SCO2', 'COX17', 'ATOX1', 'SOD1']",0.9999950490537614,0,0,7
264,Ethanol effects on histone modifications WP3996,0.6798020820374802,0.8713767465249093,0.3363109739823135,"['ALDH1A3', 'AHCY', 'ALDH1A2', 'HAT1']",0.9999950490537614,0,0,4
265,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.6798020820374802,0.8713767465249093,0.3363109739823135,"['TGFB1', 'PROM1', 'MFGE8', 'HRAS']",0.9999950490537614,0,0,4
266,White fat cell differentiation WP4149,0.6798020820374802,0.8713767465249093,0.3363109739823135,"['CEBPB', 'DDIT3', 'EBF1', 'NR2F2']",0.9999950490537614,0,0,4
267,Airway smooth muscle cell contraction WP4962,0.6839757558738149,0.871478304561605,0.33101605032718723,"['CALM1', 'CALM2']",0.9999950490537614,0,0,2
268,NOTCH1 regulation of endothelial cell calcification WP3413,0.6839757558738149,0.871478304561605,0.33101605032718723,"['VEGFA', 'DLL3']",0.9999950490537614,0,0,2
269,Phytochemical activity on NRF2 transcriptional activation WP3,0.6839757558738149,0.871478304561605,0.33101605032718723,"['AIMP2', 'CEBPB']",0.9999950490537614,0,0,2
270,Pyrimidine metabolism and related diseases WP4225,0.6839757558738149,0.871478304561605,0.33101605032718723,"['NT5C', 'TYMP']",0.9999950490537614,0,0,2
271,p38 MAPK Signaling Pathway WP400,0.6962385764317224,0.8557312252964426,0.3098285249050554,"['RPS6KA5', 'TRADD', 'DDIT3', 'HSPB1', 'HRAS']",0.9999950490537614,0,0,5
272,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.6962385764317224,0.8557312252964426,0.3098285249050554,"['CASP7', 'JUN', 'CASP8', 'TNFSF12', 'FADD']",0.9999950490537614,0,0,5
273,Canonical and non-canonical Notch signaling WP3845,0.6962933285784271,0.8457624756063563,0.30615270245191595,"['HEY1', 'NOTCH4', 'DLL3']",0.9999950490537614,0,0,3
274,Monoamine Transport WP727,0.6962933285784271,0.8457624756063563,0.30615270245191595,"['TDO2', 'ADORA2A', 'IL1R1']",0.9999950490537614,0,0,3
275,Non-small cell lung cancer WP4255,0.701129101743496,0.8783148441627047,0.31185731513354176,"['CDKN1A', 'CASP8', 'CCND1', 'GADD45B', 'EGF', 'GADD45A', 'CRABP1', 'CYCS', 'BAX', 'HRAS', 'GADD45G']",0.9999950490537614,0,0,11
276,Focal Adhesion WP306,0.703004546409193,0.9088158541658787,0.32025936381092734,"['SHC4', 'SHC3', 'ITGB4', 'TXK', 'TESK2', 'ACTB', 'MYL12B', 'ACTG1', 'RELN', 'CCND1', 'PDGFD', 'SPP1', 'FLNC', 'HRAS', 'JUN', 'LAMB3', 'EGF', 'LAMB2', 'FN1', 'VEGFB', 'VEGFC', 'VEGFA', 'MYLPF', 'MYL5', 'HCK', 'ITGA5']",0.9999950490537614,0,0,26
277,Neovascularisation processes WP4331,0.7093753096994441,0.833422087849793,0.2861725937961902,"['TGFB1', 'CXCL12', 'ANGPT1', 'NOTCH4']",0.9999950490537614,0,0,4
278,AMP-activated protein kinase (AMPK) signaling WP1403,0.7105690486352505,0.862375296912114,0.29466428477593953,"['GYS2', 'CCNA2', 'CDKN1A', 'STRADB', 'LEPR', 'HMGCR', 'EEF2', 'CPT1B', 'ACACB']",0.9999950490537614,0,0,9
279,One-carbon metabolism and related pathways WP3940,0.7109972671167304,0.8455795129439676,0.2884159196574009,"['GPX2', 'GPX4', 'CHDH', 'GAD1', 'PLD1', 'SOD1']",0.9999950490537614,0,0,6
280,Circadian rhythm related genes WP3594,0.7172683844110923,0.8978494623655914,0.2983600385581529,"['CHRNB2', 'JUN', 'MAGEL2', 'AHCY', 'HOMER1', 'SFTPC', 'NR1D1', 'CARTPT', 'HCRTR2', 'PER2', 'HTR7', 'DBP', 'NFIL3', 'ADORA2A', 'ID2', 'NOCT', 'UBC', 'CRH', 'ID3', 'PTGDS', 'ATF5', 'RPS27A', 'UBA52', 'SKP1']",0.9999950490537614,0,0,24
281,ATM Signaling Pathway WP2516,0.722016638632511,0.8261551042660488,0.2690845791600063,"['CDKN1A', 'JUN', 'GADD45A', 'H2AFX', 'BRCA1']",0.9999950490537614,0,0,5
282,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.722016638632511,0.8261551042660488,0.2690845791600063,"['IFITM3', 'JUN', 'IFITM2', 'IFI27', 'DDIT3']",0.9999950490537614,0,0,5
283,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,0.7238570434836703,0.7987893143834716,0.2581378410656708,"['RPH3AL', 'SYTL4']",0.9999950490537614,0,0,2
284,Mammalian disorder of sexual development WP4842,0.7238570434836703,0.7987893143834716,0.2581378410656708,"['FST', 'PTGDS']",0.9999950490537614,0,0,2
285,Riboflavin and CoQ disorders WP5037,0.7238570434836703,0.7987893143834716,0.2581378410656708,"['RFK', 'SLC52A1']",0.9999950490537614,0,0,2
286,Type II diabetes mellitus WP1584,0.7238570434836703,0.7987893143834716,0.2581378410656708,"['KCNJ11', 'PRKCD']",0.9999950490537614,0,0,2
287,T-cell receptor (TCR) signaling pathway WP69,0.7239578812457373,0.8554455445544554,0.27632778489718235,"['JUN', 'CD4', 'TGFB1', 'PRKCD', 'WAS', 'LCP2', 'CD247', 'VIM', 'HRAS', 'CARD11']",0.9999950490537614,0,0,10
288,Angiogenesis WP1539,0.7285767207124728,0.7987098472880464,0.25292133371874354,"['ANGPT1', 'TIMP2', 'VEGFA']",0.9999950490537614,0,0,3
289,Gastric Cancer Network 1 WP2361,0.7285767207124728,0.7987098472880464,0.25292133371874354,"['H3F3A', 'GATD3A', 'KIF15']",0.9999950490537614,0,0,3
290,IL-7 signaling pathway WP205,0.7285767207124728,0.7987098472880464,0.25292133371874354,"['CDKN1B', 'CCND1', 'IL7']",0.9999950490537614,0,0,3
291,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.7285767207124728,0.7987098472880464,0.25292133371874354,"['BMP2', 'ASCL1', 'GLI2']",0.9999950490537614,0,0,3
292,B Cell Receptor Signaling Pathway WP23,0.7315687268692663,0.8578983796830355,0.26814824316763697,"['JUN', 'GSK3A', 'TEC', 'CD81', 'PRKCD', 'GAB1', 'PTPN6', 'ETS1', 'ILF2', 'HRAS', 'CARD11', 'RASGRP3']",0.9999950490537614,0,0,12
293,Aspirin and miRNAs WP4707,0.7346161853368119,0.7988687187582215,0.2463767952040191,['VEGFA'],0.9999950490537614,0,0,1
294,"Cerebral organic acidurias, including diseases WP4519",0.7346161853368119,0.7988687187582215,0.2463767952040191,['MDH2'],0.9999950490537614,0,0,1
295,Cholesterol Biosynthesis with Skeletal Dysplasias WP4804,0.7346161853368119,0.7988687187582215,0.2463767952040191,['DHCR7'],0.9999950490537614,0,0,1
296,Estrogen metabolism WP697,0.7346161853368119,0.7988687187582215,0.2463767952040191,['ARSD'],0.9999950490537614,0,0,1
297,Glucuronidation WP698,0.7346161853368119,0.7988687187582215,0.2463767952040191,['PGM5'],0.9999950490537614,0,0,1
298,Liver X receptor pathway WP2874,0.7346161853368119,0.7988687187582215,0.2463767952040191,['ABCG5'],0.9999950490537614,0,0,1
299,Serotonin Transporter Activity WP1455,0.7346161853368119,0.7988687187582215,0.2463767952040191,['IL1R1'],0.9999950490537614,0,0,1
300,GABA receptor Signaling WP4159,0.7369012527256265,0.798630317397603,0.2438229389829107,"['SLC32A1', 'GABRA6', 'GAD1', 'AP2M1']",0.9999950490537614,0,0,4
301,The influence of laminopathies on Wnt signaling WP4844,0.7369012527256265,0.798630317397603,0.2438229389829107,"['CEBPB', 'CCND1', 'TCF7', 'SPP1']",0.9999950490537614,0,0,4
302,Zinc homeostasis WP3529,0.7369012527256265,0.798630317397603,0.2438229389829107,"['SLC39A11', 'SLC39A8', 'SLC39A7', 'SLC39A3']",0.9999950490537614,0,0,4
303,Phosphodiesterases in neuronal function WP4222,0.7451616238253592,0.8179318462488422,0.24059803832090088,"['ADCY10', 'PDE10A', 'ADORA2A', 'PDE6C', 'PDE5A', 'PDE6B', 'CHRFAM7A']",0.9999950490537614,0,0,7
304,PPAR signaling pathway WP3942,0.7451616238253592,0.8179318462488422,0.24059803832090088,"['CPT2', 'FABP6', 'ACSL5', 'ANGPTL4', 'CPT1B', 'ACSBG2', 'PCK2']",0.9999950490537614,0,0,7
305,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.7461874606458415,0.7985507246376812,0.23379842153895428,"['MAP1LC3A', 'MSTN', 'IGFBP5', 'TNFSF9', 'PLD1']",0.9999950490537614,0,0,5
306,Eukaryotic Transcription Initiation WP405,0.7555861885793465,0.7984710689337023,0.2237806374192686,"['TAF13', 'POLR2E', 'TAF7', 'POLR2I', 'POLR3K', 'POLR2K']",0.9999950490537614,0,0,6
307,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.7555861885793465,0.7984710689337023,0.2237806374192686,"['CCNA2', 'CDKN1A', 'HSP90AA1', 'JUN', 'CCND1', 'BAX']",0.9999950490537614,0,0,6
308,AGE/RAGE pathway WP2324,0.755674982337546,0.815364278557536,0.22841933934151107,"['MSR1', 'JUN', 'CASP8', 'PRKCD', 'CYCS', 'FOXO4', 'TIRAP', 'SOD1']",0.9999950490537614,0,0,8
309,Oncostatin M Signaling Pathway WP2374,0.755674982337546,0.815364278557536,0.22841933934151107,"['CASP7', 'CEBPB', 'CDKN1B', 'PRKCH', 'PRKCD', 'HRAS', 'LDLR', 'VEGFA']",0.9999950490537614,0,0,8
310,Physiological and pathological hypertrophy of the heart WP1528,0.7580981297379551,0.756610127213769,0.20953745700009116,"['JUN', 'CALM1', 'CALM2']",0.9999950490537614,0,0,3
311,MAP3K1 role in promoting and blocking gonadal determination WP4872,0.7593918149209904,0.7372832457712047,0.20292793070205215,"['FRAT1', 'GADD45G']",0.9999950490537614,0,0,2
312,Photodynamic therapy-induced NF-kB survival signaling WP3617,0.7593918149209904,0.7372832457712047,0.20292793070205215,"['CCND1', 'VEGFA']",0.9999950490537614,0,0,2
313,PPAR-alpha pathway WP2878,0.7593918149209904,0.7372832457712047,0.20292793070205215,"['CCND1', 'CPT2']",0.9999950490537614,0,0,2
314,Tumor suppressor activity of SMARCB1 WP4204,0.7624074078639472,0.7666218885815883,0.20796474733446668,"['H3F3B', 'H3F3A', 'GLI3', 'GLI2']",0.9999950490537614,0,0,4
315,NO/cGMP/PKG mediated Neuroprotection WP4008,0.7687649199245078,0.7727272727272727,0.20320413110471214,"['CNGB3', 'CYCS', 'CNGA4', 'CALM1', 'CALM2']",0.9999950490537614,0,0,5
316,Canonical NF-KB pathway WP4562,0.7804434787715941,0.6846882399368587,0.1697293933394113,['NFKBIE'],0.9999950490537614,0,0,1
317,"Degradation pathway of sphingolipids, including diseases WP4153",0.7804434787715941,0.6846882399368587,0.1697293933394113,['NEU1'],0.9999950490537614,0,0,1
318,Folate-Alcohol and Cancer Pathway Hypotheses WP1589,0.7804434787715941,0.6846882399368587,0.1697293933394113,['CEBPB'],0.9999950490537614,0,0,1
319,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.7804434787715941,0.6846882399368587,0.1697293933394113,['ELOB'],0.9999950490537614,0,0,1
320,Interleukin-1 Induced Activation of NF-kappa-B WP3656,0.7804434787715941,0.6846882399368587,0.1697293933394113,['TIFA'],0.9999950490537614,0,0,1
321,Leptin and adiponectin WP3934,0.7804434787715941,0.6846882399368587,0.1697293933394113,['LEPR'],0.9999950490537614,0,0,1
322,Mitochondrial CII Assembly WP4920,0.7804434787715941,0.6846882399368587,0.1697293933394113,['SDHAF1'],0.9999950490537614,0,0,1
323,Nephrogenesis WP5052,0.7804434787715941,0.6846882399368587,0.1697293933394113,['ALDH1A2'],0.9999950490537614,0,0,1
324,TFs regulate miRNAs related to cardiac hypertrophy WP1559,0.7804434787715941,0.6846882399368587,0.1697293933394113,['TGFB1'],0.9999950490537614,0,0,1
325,Apoptosis WP254,0.7821265197168291,0.7982317234098707,0.19615647518391569,"['CASP7', 'JUN', 'CASP8', 'TRADD', 'IRF1', 'CYCS', 'BAX', 'FADD', 'NFKBIE']",0.9999950490537614,0,0,9
326,Neural Crest Differentiation WP2064,0.7821265197168291,0.7982317234098707,0.19615647518391569,"['DLX5', 'NOTCH4', 'MYB', 'ZIC1', 'ASCL1', 'ETS1', 'GFAP', 'RHOB', 'DLL3']",0.9999950490537614,0,0,9
327,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.7832722890062822,0.7797597144539299,0.19047572040598112,"['IFI27L2', 'JUN', 'PRKCH', 'PRKCD', 'ISG15', 'ETS1', 'HRAS']",0.9999950490537614,0,0,7
328,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.7832722890062822,0.7797597144539299,0.19047572040598112,"['DDX3Y', 'CASP8', 'RNF125', 'CXCL12', 'TRADD', 'ISG15', 'FADD']",0.9999950490537614,0,0,7
329,16p11.2 distal deletion syndrome WP4950,0.7849649210175695,0.7187203791469194,0.17401388213518515,"['C3', 'PLN', 'CD81']",0.9999950490537614,0,0,3
330,Globo Sphingolipid Metabolism WP1424,0.7908917914820219,0.6845637583892618,0.16059463263099782,"['FUT2', 'ST3GAL1']",0.9999950490537614,0,0,2
331,Glycosaminoglycan degradation WP4815,0.7908917914820219,0.6845637583892618,0.16059463263099782,"['HYAL1', 'HYAL2']",0.9999950490537614,0,0,2
332,miRNA targets in ECM and membrane receptors WP2911,0.7908917914820219,0.6845637583892618,0.16059463263099782,"['LAMB2', 'FN1']",0.9999950490537614,0,0,2
333,Transcription factor regulation in adipogenesis WP3599,0.7908917914820219,0.6845637583892618,0.16059463263099782,"['CEBPB', 'PCK2']",0.9999950490537614,0,0,2
334,Pancreatic adenocarcinoma pathway WP4263,0.7918856789462564,0.8092981192745056,0.18884020068968313,"['CDKN1A', 'TGFB1', 'CCND1', 'GADD45B', 'EGF', 'GADD45A', 'PRKCD', 'PEBP1', 'BAX', 'PLD1', 'VEGFA', 'GADD45G']",0.9999950490537614,0,0,12
335,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.7946492991168072,0.8720833333333333,0.20045218683519675,"['CDKN1A', 'CDKN1B', 'HSP90AB1', 'ITGB4', 'HIF3A', 'FGF1', 'GYS2', 'GHR', 'GNG3', 'RELN', 'PPP2R1A', 'GNG4', 'PDGFD', 'SPP1', 'PELO', 'HRAS', 'HSP90AA1', 'ANGPT2', 'ANGPT1', 'LAMB3', 'EGF', 'LAMB2', 'FN1', 'VEGFB', 'VEGFC', 'PRLR', 'EPOR', 'VEGFA', 'FGF17', 'EFNA3', 'LPAR6', 'DDIT4', 'IL3RA', 'ITGA5', 'FGFR4']",0.9999950490537614,0,0,35
336,Nucleotide Excision Repair WP4753,0.7949177619500558,0.7563214085034651,0.17358832859882048,"['PCNA', 'CETN2', 'POLD1', 'RPA3', 'POLE2', 'POLE3']",0.9999950490537614,0,0,6
337,Integrated breast cancer pathway WP1984,0.7955522771967256,0.8397335286526455,0.19206277547523756,"['PLK3', 'JUN', 'GSK3A', 'GADD45A', 'TRADD', 'DCAKD', 'ODC1', 'PHB', 'BRCA1', 'HMGCR', 'JAKMIP1', 'BACH1', 'RASGRP3', 'FOSL2', 'VEGFA', 'CASP8', 'CCND1', 'BAX', 'FADD', 'FAU']",0.9999950490537614,0,0,20
338,Glioblastoma signaling pathways WP2261,0.797957059736378,0.7980718436344427,0.18012520842546684,"['CDKN1A', 'CDKN1B', 'PRKCH', 'CDKN2C', 'CCND1', 'PRKCD', 'GAB1', 'SPRY2', 'BRCA1', 'FOXO4', 'HRAS']",0.9999950490537614,0,0,11
339,DNA IR-double strand breaks and cellular response via ATM WP3959,0.8006581507538933,0.7619749712313003,0.16940319080808303,"['YAP1', 'PCNA', 'KAT5', 'CDK5', 'H2AFX', 'BAX', 'BRCA1']",0.9999950490537614,0,0,7
340,Notch Signaling Pathway Netpath WP61,0.8006581507538933,0.7619749712313003,0.16940319080808303,"['PSENEN', 'CDKN1A', 'CCND1', 'HEY1', 'NOTCH4', 'SKP1', 'DLL3']",0.9999950490537614,0,0,7
341,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.8066444517124595,0.7662524732884843,0.16464642218104258,"['YAP1', 'CASP7', 'ANGPT2', 'ANGPT1', 'FN1', 'BAX', 'HRAS', 'ANGPTL1']",0.9999950490537614,0,0,8
342,BDNF-TrkB Signaling WP3676,0.807580307208227,0.7097180151308954,0.15167580802777422,"['TRPC3', 'HOMER1', 'GAB1', 'HRAS']",0.9999950490537614,0,0,4
343,miRNA regulation of prostate cancer signaling pathways WP3981,0.807580307208227,0.7097180151308954,0.15167580802777422,"['CDKN1A', 'CDKN1B', 'CCND1', 'TCF7']",0.9999950490537614,0,0,4
344,IL-6 signaling pathway WP364,0.8092702091603693,0.7257755419810755,0.15359037205944023,"['HCK', 'IRF1', 'PRKCD', 'GAB1', 'VIP']",0.9999950490537614,0,0,5
345,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.8093096075045322,0.6844391785150079,0.14480935076078918,"['CCND1', 'FGF1', 'GLI2']",0.9999950490537614,0,0,3
346,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.812685275689639,0.7695961995249406,0.1596229937443637,"['IDI1', 'SQLE', 'GSK3A', 'RBP4', 'HMGCS1', 'INSIG1', 'HMGCR', 'LDLR', 'FDFT1']",0.9999950490537614,0,0,9
347,15q11.2 copy number variation syndrome WP4940,0.8183597038247502,0.5990528808208366,0.12008212881654988,['TUBGCP4'],0.9999950490537614,0,0,1
348,Biotin Metabolism (including IEMs) WP5031,0.8183597038247502,0.5990528808208366,0.12008212881654988,['ACACB'],0.9999950490537614,0,0,1
349,Cytosine methylation WP3585,0.8183597038247502,0.5990528808208366,0.12008212881654988,['TDG'],0.9999950490537614,0,0,1
350,Estrogen Receptor Pathway WP2881,0.8183597038247502,0.5990528808208366,0.12008212881654988,['JUN'],0.9999950490537614,0,0,1
351,Purine metabolism WP4792,0.8183597038247502,0.5990528808208366,0.12008212881654988,['PRPS1'],0.9999950490537614,0,0,1
352,Vitamin B12 Disorders WP4271,0.8183597038247502,0.5990528808208366,0.12008212881654988,['CUBN'],0.9999950490537614,0,0,1
353,Retinoblastoma gene in cancer WP2446,0.8186732947473307,0.7722772277227723,0.15450964567967929,"['CCNA2', 'CDKN1A', 'CDKN1B', 'PCNA', 'CCND1', 'H2AFZ', 'KIF4A', 'RPA3', 'POLE2', 'DCK']",0.9999950490537614,0,0,10
354,Ebstein-Barr virus LMP1 signaling WP262,0.8186906035821999,0.6388735359915778,0.12780603749731195,"['HSP90AA1', 'TRADD']",0.9999950490537614,0,0,2
355,Proteoglycan biosynthesis WP4784,0.8186906035821999,0.6388735359915778,0.12780603749731195,"['B4GALT7', 'PAPSS2']",0.9999950490537614,0,0,2
356,Common Pathways Underlying Drug Addiction WP2636,0.8272926983162275,0.7043710764938387,0.13354644488221215,"['PPP1R1A', 'CALM1', 'CALM2', 'ACTB', 'ACTG1']",0.9999950490537614,0,0,5
357,Fatty acid beta-oxidation WP143,0.8273977648457513,0.6843145001975504,0.12965688110870727,"['TPI1', 'CPT2', 'ACSL5', 'CPT1B']",0.9999950490537614,0,0,4
358,Prostaglandin Synthesis and Regulation WP98,0.8273977648457513,0.6843145001975504,0.12965688110870727,"['HSD11B1', 'HPGD', 'ANXA2', 'PTGDS']",0.9999950490537614,0,0,4
359,Signal transduction through IL1R WP4496,0.8312814457966203,0.6532744506678156,0.12071653327981434,"['JUN', 'TGFB1', 'IL1R1']",0.9999950490537614,0,0,3
360,Sphingolipid pathway WP1422,0.8312814457966203,0.6532744506678156,0.12071653327981434,"['CERS4', 'SPHK1', 'SERINC1']",0.9999950490537614,0,0,3
361,TNF-alpha signaling pathway WP231,0.8368087917266354,0.7631835825351984,0.13596854235819372,"['CASP7', 'HSP90AA1', 'JUN', 'CASP8', 'TRADD', 'RFK', 'BAX', 'FADD', 'NFKBIE', 'HRAS', 'SKP1']",0.9999950490537614,0,0,11
362,Wnt signaling pathway and pluripotency WP399,0.8368087917266354,0.7631835825351984,0.13596854235819372,"['FRAT1', 'JUN', 'PRKCH', 'CCND1', 'PPP2R1A', 'PRKCD', 'TCF7', 'ESRRB', 'ZBTB33', 'WNT16', 'LDLR']",0.9999950490537614,0,0,11
363,Head and Neck Squamous Cell Carcinoma WP4674,0.8398825552135867,0.7429355393562126,0.12963720867653475,"['CDKN1A', 'CASP8', 'CCND1', 'DDIT4', 'GAB1', 'FAT1', 'FADD', 'HRAS', 'VEGFA']",0.9999950490537614,0,0,9
364,Eicosanoid metabolism via cyclooxygenases (COX) WP4719,0.8431269496072624,0.5988945913936045,0.10219401937257185,"['HPGD', 'PTGDS']",0.9999950490537614,0,0,2
365,"Relationship between inflammation, COX-2 and EGFR WP4483",0.8431269496072624,0.5988945913936045,0.10219401937257185,"['PTGES2', 'HRAS']",0.9999950490537614,0,0,2
366,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.8431269496072624,0.5988945913936045,0.10219401937257185,"['MDH2', 'IDH3B']",0.9999950490537614,0,0,2
367,Type 2 papillary renal cell carcinoma WP4241,0.8454886538517273,0.6606629518113326,0.11088602010721582,"['CDKN1A', 'TGFB1', 'ELOB', 'VEGFA']",0.9999950490537614,0,0,4
368,Cancer immunotherapy by CTLA4 blockade WP4582,0.8497300830367994,0.532447601508375,0.08670191946145599,['PTPN6'],0.9999950490537614,0,0,1
369,Ethanol metabolism resulting in production of ROS by CYP2E1 WP4269,0.8497300830367994,0.532447601508375,0.08670191946145599,['MAFF'],0.9999950490537614,0,0,1
370,MFAP5-mediated ovarian cancer cell motility and invasiveness WP3301,0.8497300830367994,0.532447601508375,0.08670191946145599,['JUN'],0.9999950490537614,0,0,1
371,Osteopontin Signaling WP1434,0.8497300830367994,0.532447601508375,0.08670191946145599,['SPP1'],0.9999950490537614,0,0,1
372,TCA cycle in senescence WP5050,0.8497300830367994,0.532447601508375,0.08670191946145599,['GOT1'],0.9999950490537614,0,0,1
373,One-carbon metabolism WP241,0.8510395839193301,0.6248196991551618,0.10078131614055151,"['AHCY', 'CHDH', 'MAT2B']",0.9999950490537614,0,0,3
374,Wnt signaling WP428,0.8527191467523264,0.7557419112585269,0.12040860965189226,"['SFRP4', 'FRAT1', 'JUN', 'FRAT2', 'CCND1', 'CSNK2B', 'TCF7', 'GPC4', 'NOTUM', 'WNT16', 'DKK1', 'CXXC4']",0.9999950490537614,0,0,12
375,3q29 copy number variation syndrome WP4906,0.8596568866996319,0.6982463080168776,0.1055901601075867,"['CASP7', 'JUN', 'TGFB1', 'DYNLT3', 'SLC51A', 'DYNLRB1', 'DYNLL2']",0.9999950490537614,0,0,7
376,Target Of Rapamycin (TOR) Signaling WP1471,0.8619515553839023,0.6385881733175293,0.09486623887366127,"['IDI1', 'RRAGA', 'DDIT4', 'HMGCR']",0.9999950490537614,0,0,4
377,DNA damage response (only ATM dependent) WP710,0.8630398995670749,0.7458653118581775,0.1098617503267809,"['FRAT1', 'JUN', 'CDKN1A', 'TGFB1', 'CDKN1B', 'CCND1', 'TCF7', 'BAX', 'WNT16', 'HRAS', 'LDLR', 'PCK2']",0.9999950490537614,0,0,12
378,Amino Acid metabolism WP3925,0.8638851236346495,0.7180522565320665,0.1050621589812406,"['MPST', 'LDHA', 'PKM', 'TDO2', 'GOT1', 'MDH2', 'ODC1', 'PYCR1', 'HIBCH']",0.9999950490537614,0,0,9
379,Immune response to tuberculosis WP4197,0.8645329110901725,0.5636190520424514,0.0820437174279779,"['IRF1', 'IFIT3']",0.9999950490537614,0,0,2
380,Metabolism of Spingolipids in ER and Golgi apparatus WP4142,0.8645329110901725,0.5636190520424514,0.0820437174279779,"['SPHK1', 'B3GALT1']",0.9999950490537614,0,0,2
381,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.8645329110901725,0.5636190520424514,0.0820437174279779,"['HTR2B', 'HRAS']",0.9999950490537614,0,0,2
382,Serotonin Receptor 4/6/7 and NR3C Signaling WP734,0.8645329110901725,0.5636190520424514,0.0820437174279779,"['HTR7', 'RPS6KA5']",0.9999950490537614,0,0,2
383,Triacylglyceride synthesis WP325,0.8645329110901725,0.5636190520424514,0.0820437174279779,"['MOGAT1', 'AGPAT1']",0.9999950490537614,0,0,2
384,IL17 signaling pathway WP2112,0.868747578295933,0.5987361769352291,0.08424377852881186,"['CEBPB', 'TRAF3IP2', 'IL17RE']",0.9999950490537614,0,0,3
385,Intraflagellar transport proteins binding to dynein WP4532,0.868747578295933,0.5987361769352291,0.08424377852881186,"['DYNLT3', 'DYNLRB1', 'DYNLL2']",0.9999950490537614,0,0,3
386,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.868747578295933,0.5987361769352291,0.08424377852881186,"['YAP1', 'FOXO4', 'FERMT3']",0.9999950490537614,0,0,3
387,ATM Signaling Network in Development and Disease  WP3878,0.8731760780643645,0.6470996688387993,0.08775839549821213,"['KAT5', 'CDK5', 'H2AFX', 'HSPB1', 'CDK5R1']",0.9999950490537614,0,0,5
388,15q13.3 copy number variation syndrome WP4942,0.8756843183171457,0.4791633780584057,0.06360875645650585,['CHRFAM7A'],0.9999950490537614,0,0,1
389,Bone morphogenic protein (BMP) signaling and regulation WP1425,0.8756843183171457,0.4791633780584057,0.06360875645650585,['BMP2'],0.9999950490537614,0,0,1
390,Homologous recombination WP186,0.8756843183171457,0.4791633780584057,0.06360875645650585,['POLD1'],0.9999950490537614,0,0,1
391,Leptin Insulin Overlap WP3935,0.8756843183171457,0.4791633780584057,0.06360875645650585,['LEPR'],0.9999950490537614,0,0,1
392,"NAD metabolism, sirtuins and aging WP3630",0.8756843183171457,0.4791633780584057,0.06360875645650585,['ROS1'],0.9999950490537614,0,0,1
393,ncRNAs involved in STAT3 signaling in hepatocellular carcinoma WP4337,0.8756843183171457,0.4791633780584057,0.06360875645650585,['SOX4'],0.9999950490537614,0,0,1
394,Neuroinflammation WP4919,0.8756843183171457,0.4791633780584057,0.06360875645650585,['JUN'],0.9999950490537614,0,0,1
395,Serotonin and anxiety-related events WP3944,0.8756843183171457,0.4791633780584057,0.06360875645650585,['CRH'],0.9999950490537614,0,0,1
396,Netrin-UNC5B signaling pathway WP4747,0.8768888239938848,0.6179375740813907,0.08118158783735913,"['YAP1', 'JUN', 'ITGB4', 'NTN1']",0.9999950490537614,0,0,4
397,miRNA regulation of p53 pathway in prostate cancer WP3982,0.8832261484556037,0.5322630170636488,0.06609322649881576,"['CASP8', 'BAX']",0.9999950490537614,0,0,2
398,p53 transcriptional gene network WP4963,0.8838958666444721,0.6528631510837917,0.08057377249270543,"['BTG2', 'CDKN1A', 'GADD45A', 'BAX', 'ISG15', 'RPRM']",0.9999950490537614,0,0,6
399,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.884569097406068,0.574739336492891,0.07049445108556683,"['CDKN1B', 'FOXO4', 'HRAS']",0.9999950490537614,0,0,3
400,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.884569097406068,0.574739336492891,0.07049445108556683,"['CASP8', 'TGFB1', 'BAX']",0.9999950490537614,0,0,3
401,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.884569097406068,0.574739336492891,0.07049445108556683,"['CALM3', 'CALM1', 'CALM2']",0.9999950490537614,0,0,3
402,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.8859754742073443,0.6300187226960682,0.0762738531344152,"['ADCY10', 'TGFB1', 'CFL1', 'BANF1', 'HRAS']",0.9999950490537614,0,0,5
403,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.8938550527306646,0.6570101141722512,0.073724189217473,"['ITGB4', 'TCF7', 'CTNNA3', 'ITGA5', 'ACTB', 'SGCG', 'ACTG1']",0.9999950490537614,0,0,7
404,Cell Differentiation - Index expanded WP2023,0.8971572078482531,0.43556719523570353,0.04726956951557519,['ID2'],0.9999950490537614,0,0,1
405,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.8971572078482531,0.43556719523570353,0.04726956951557519,['CCK'],0.9999950490537614,0,0,1
406,Interactions between immune cells and microRNAs in tumor microenvironment WP4559,0.8971572078482531,0.43556719523570353,0.04726956951557519,['TGFB1'],0.9999950490537614,0,0,1
407,NO metabolism in cystic fibrosis WP4947,0.8971572078482531,0.43556719523570353,0.04726956951557519,['DDAH2'],0.9999950490537614,0,0,1
408,Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds WP3664,0.8971572078482531,0.43556719523570353,0.04726956951557519,['SFRP4'],0.9999950490537614,0,0,1
409,Melatonin metabolism and effects WP3298,0.8986646371967052,0.5525884068538097,0.05904150390949647,"['PER2', 'CALM1', 'CALM2']",0.9999950490537614,0,0,3
410,Nuclear receptors WP170,0.8986646371967052,0.5525884068538097,0.05904150390949647,"['NR4A1', 'ESRRB', 'NR2F2']",0.9999950490537614,0,0,3
411,Fatty Acid Biosynthesis WP357,0.8995049863424777,0.5042076173457727,0.05340097269664466,"['ACSL5', 'ACACB']",0.9999950490537614,0,0,2
412,Glycerolipids and Glycerophospholipids WP4722,0.8995049863424777,0.5042076173457727,0.05340097269664466,"['PLD1', 'CDIPT']",0.9999950490537614,0,0,2
413,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.8995049863424777,0.5042076173457727,0.05340097269664466,"['ANGPT2', 'LTBP1']",0.9999950490537614,0,0,2
414,NRF2-ARE regulation WP4357,0.8995049863424777,0.5042076173457727,0.05340097269664466,"['AIMP2', 'CEBPB']",0.9999950490537614,0,0,2
415,PKC-gamma calcium signaling pathway in ataxia WP4760,0.8995049863424777,0.5042076173457727,0.05340097269664466,"['TRPC3', 'HOMER3']",0.9999950490537614,0,0,2
416,Toll-like Receptor Signaling related to MyD88 WP3858,0.8995049863424777,0.5042076173457727,0.05340097269664466,"['TICAM2', 'TIRAP']",0.9999950490537614,0,0,2
417,Osteoblast differentiation WP4787,0.9049531909747702,0.6924889482025189,0.06916029729925968,"['BMP2', 'PRKCH', 'HEY1', 'NOTCH4', 'PRKCD', 'FGF1', 'FGFR4', 'WNT16', 'GLI3', 'GLI2', 'DLL3']",0.9999950490537614,0,0,11
418,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.9111890849773151,0.5320782868176233,0.049485858941956354,"['PRKCH', 'PRKCD', 'HRAS']",0.9999950490537614,0,0,3
419,Estrogen signaling pathway WP712,0.9136456232309152,0.4789577575996842,0.04325587414282668,"['JUN', 'GPER1']",0.9999950490537614,0,0,2
420,SARS-CoV-2 mitochondrial interactions WP5038,0.9136456232309152,0.4789577575996842,0.04325587414282668,"['NDUFB9', 'PHB']",0.9999950490537614,0,0,2
421,Signal Transduction of S1P Receptor WP26,0.9136456232309152,0.4789577575996842,0.04325587414282668,"['SPHK1', 'S1PR3']",0.9999950490537614,0,0,2
422,Sphingolipid Metabolism (general overview) WP4725,0.9136456232309152,0.4789577575996842,0.04325587414282668,"['CERS4', 'SPHK1']",0.9999950490537614,0,0,2
423,Wnt/beta-catenin signaling pathway in leukemia WP3658,0.9136456232309152,0.4789577575996842,0.04325587414282668,"['CCND1', 'DKK1']",0.9999950490537614,0,0,2
424,MAPK Signaling Pathway WP382,0.9173366804921418,0.7740461997351608,0.06678526328040016,"['RASGRF2', 'HSPB1', 'FGF1', 'RASGRP3', 'RPS6KA5', 'DUSP10', 'NTF3', 'MKNK2', 'FLNC', 'HRAS', 'DUSP4', 'HSPA8', 'JUN', 'DUSP2', 'TGFB1', 'HSPA1L', 'IL1R1', 'GADD45A', 'DUSP1', 'EGF', 'PRKCD', 'DUSP7', 'FGF17', 'NR4A1', 'MAPKAPK3', 'DDIT3', 'FGFR4', 'HSPA1B', 'HSPA1A']",0.9999950490537614,0,0,29
425,Cannabinoid receptor signaling WP3869,0.9259008799416459,0.4561126464008422,0.035115242002617196,"['ADORA2A', 'PRKAR1A']",0.9999950490537614,0,0,2
426,Cell migration and invasion through p75NTR WP4561,0.9259008799416459,0.4561126464008422,0.035115242002617196,"['JUN', 'EFNA3']",0.9999950490537614,0,0,2
427,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.9259008799416459,0.4561126464008422,0.035115242002617196,"['H3F3B', 'H3F3A']",0.9999950490537614,0,0,2
428,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.9259008799416459,0.4561126464008422,0.035115242002617196,"['TICAM2', 'TIRAP']",0.9999950490537614,0,0,2
429,Fluoropyrimidine Activity WP1601,0.9259008799416459,0.4561126464008422,0.035115242002617196,"['TDG', 'TYMP']",0.9999950490537614,0,0,2
430,MTHFR deficiency WP4288,0.9259008799416459,0.4561126464008422,0.035115242002617196,"['CHDH', 'CYCS']",0.9999950490537614,0,0,2
431,Sphingolipid Metabolism (integrated pathway) WP4726,0.9259008799416459,0.4561126464008422,0.035115242002617196,"['CERS4', 'SPHK1']",0.9999950490537614,0,0,2
432,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.9282666789448745,0.6090261795166858,0.04533360542113785,"['JUN', 'CDKN1B', 'PAX8', 'PLD1', 'HRAS', 'TSHR', 'MYL12B']",0.9999950490537614,0,0,7
433,NAD+ metabolism WP3644,0.929619519826951,0.36849614473923864,0.02689280995549654,['NMNAT1'],0.9999950490537614,0,0,1
434,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.929619519826951,0.36849614473923864,0.02689280995549654,['LDHA'],0.9999950490537614,0,0,1
435,Serotonin and anxiety WP3947,0.929619519826951,0.36849614473923864,0.02689280995549654,['CRH'],0.9999950490537614,0,0,1
436,Transcription co-factors SKI and SKIL protein partners WP4533,0.929619519826951,0.36849614473923864,0.02689280995549654,['SATB2'],0.9999950490537614,0,0,1
437,Regulation of Microtubule Cytoskeleton WP2038,0.9322803187094861,0.5318934105974802,0.03729729057949591,"['SPRED1', 'PARD6A', 'CFL2', 'TESK2']",0.9999950490537614,0,0,4
438,FGFR3 signaling in chondrocyte proliferation and terminal differentiation WP4767,0.936500039082777,0.4353443634928041,0.02856107839714621,"['CDKN1A', 'BMP2']",0.9999950490537614,0,0,2
439,MET in type 1 papillary renal cell carcinoma WP4205,0.9378087581693345,0.5742348754448399,0.036871181093019796,"['CDKN1A', 'JUN', 'RPL11', 'GAB1', 'ETS1', 'HRAS']",0.9999950490537614,0,0,6
440,Histone Modifications WP2369,0.9401833141843476,0.5174751994190951,0.031918081244446624,"['SET', 'H3F3B', 'H3F3A', 'HIST1H4C']",0.9999950490537614,0,0,4
441,Amyotrophic lateral sclerosis (ALS) WP2447,0.9407681189246911,0.4787519747235387,0.029231920349312004,"['BAX', 'NEFH', 'SOD1']",0.9999950490537614,0,0,3
442,Disruption of postsynaptic signaling by CNV WP4875,0.9407681189246911,0.4787519747235387,0.029231920349312004,"['HOMER1', 'YWHAG', 'SHANK1']",0.9999950490537614,0,0,3
443,Canonical and non-canonical TGF-B signaling WP3874,0.9417785769672922,0.3421468034727703,0.020523706229450593,['TGFB1'],0.9999950490537614,0,0,1
444,MAPK pathway in congenital thyroid cancer WP4928,0.9417785769672922,0.3421468034727703,0.020523706229450593,['JUN'],0.9999950490537614,0,0,1
445,MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement WP4560,0.9417785769672922,0.3421468034727703,0.020523706229450593,['JUN'],0.9999950490537614,0,0,1
446,Gastrin signaling pathway WP4659,0.9426126362389502,0.6520376175548589,0.038535331165408644,"['JUN', 'BMP2', 'CDKN1A', 'PRKCH', 'CDKN1B', 'CCND1', 'KAT5', 'ANXA2', 'PRKCD', 'HRAS', 'RHOB', 'VEGFA']",0.9999950490537614,0,0,12
447,Gastric Cancer Network 2 WP2363,0.9456494353494428,0.41638201822894316,0.023268823870057267,"['SNURF', 'CACYBP']",0.9999950490537614,0,0,2
448,Regulation of toll-like receptor signaling pathway WP1449,0.9480997885013359,0.6210621062106211,0.033099827986369006,"['JUN', 'TICAM2', 'CASP8', 'PELI3', 'SFTPD', 'TIFA', 'SPP1', 'PTPN6', 'FADD', 'TIRAP']",0.9999950490537614,0,0,10
449,IL-5 signaling pathway WP127,0.9483954906071386,0.46327014218009477,0.024545756753487295,"['GSK3A', 'SPRED1', 'JUN']",0.9999950490537614,0,0,3
450,Signaling of Hepatocyte Growth Factor Receptor WP313,0.9483954906071386,0.46327014218009477,0.024545756753487295,"['JUN', 'GAB1', 'HRAS']",0.9999950490537614,0,0,3
451,Vitamin D-sensitive calcium signaling in depression WP4698,0.9483954906071386,0.46327014218009477,0.024545756753487295,"['CALB1', 'GPX4', 'PVALB']",0.9999950490537614,0,0,3
452,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.9490418352339913,0.6062527182094944,0.031708470866509963,"['SHC4', 'SHC3', 'CCND1', 'EGF', 'PDGFD', 'GAB1', 'BAX', 'HRAS', 'VEGFA']",0.9999950490537614,0,0,9
453,DNA Repair Pathways Full Network WP4946,0.951587562638206,0.6560577424146969,0.03255592768919925,"['FEN1', 'PCNA', 'CENPX', 'CETN2', 'H2AFX', 'APEX2', 'BRCA1', 'BRIP1', 'NEIL2', 'POLD1', 'TDG', 'RPA3', 'POLE2', 'POLE3']",0.9999950490537614,0,0,14
454,Hepatitis B infection WP4666,0.951587562638206,0.6560577424146969,0.03255592768919925,"['JUN', 'CDKN1A', 'TICAM2', 'TGFB1', 'PCNA', 'ATP6AP1', 'SLC10A1', 'YWHAB', 'TIRAP', 'CASP8', 'CYCS', 'BAX', 'FADD', 'HRAS']",0.9999950490537614,0,0,14
455,BMP Signaling Pathway in Eyelid Development WP3927,0.9518376331404764,0.3193107077084978,0.01576143586404511,['JUN'],0.9999950490537614,0,0,1
456,Mitochondrial LC-Fatty Acid Beta-Oxidation WP368,0.9518376331404764,0.3193107077084978,0.01576143586404511,['CPT2'],0.9999950490537614,0,0,1
457,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.9518376331404764,0.3193107077084978,0.01576143586404511,['NFKBIE'],0.9999950490537614,0,0,1
458,22q11.2 copy number variation syndrome WP4657,0.9526747199043243,0.613048997207413,0.02972169179604973,"['CLDN5', 'CYP26A1', 'RANBP1', 'MRPL40', 'RELN', 'SERPIND1', 'THAP7', 'ALDH1A2', 'HIST1H4C', 'RAN']",0.9999950490537614,0,0,10
459,Nanoparticle-mediated activation of receptor signaling WP2643,0.9535335439248374,0.39899986840373736,0.018984682974035546,"['FN1', 'HRAS']",0.9999950490537614,0,0,2
460,Trans-sulfuration and one-carbon metabolism WP2525,0.9535335439248374,0.39899986840373736,0.018984682974035546,"['AHCY', 'MAT2B']",0.9999950490537614,0,0,2
461,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.9552069453831681,0.5797268290343083,0.026567295161161193,"['MC4R', 'TG', 'PAX8', 'MAPKAPK3', 'NPY', 'DIO1', 'HRAS', 'TSHR']",0.9999950490537614,0,0,8
462,Pathways affected in adenoid cystic carcinoma WP3651,0.9552890580984337,0.5415967232928222,0.02477334126580515,"['MYCBP', 'MYB', 'BRCA1', 'FGFR4', 'HRAS', 'FOXP2']",0.9999950490537614,0,0,6
463,G Protein Signaling Pathways WP35,0.9579981033878927,0.5895454397553119,0.02529708871337724,"['GNG3', 'PRKCH', 'PRKD3', 'PRKAR1A', 'GNG4', 'PRKCD', 'CALM1', 'HRAS', 'CALM2']",0.9999950490537614,0,0,9
464,IL-4 signaling pathway WP395,0.9591068453033844,0.47854602923745554,0.01998063524176041,"['CEBPB', 'HRH1', 'NFIL3', 'PTPN6']",0.9999950490537614,0,0,4
465,Corticotropin-releasing hormone signaling pathway WP2355,0.9595384647035166,0.5710269389105127,0.023585054884221166,"['CRHBP', 'NR4A1', 'HSP90AA1', 'TGFB1', 'PRKCD', 'IL18', 'CRH', 'FOSL2']",0.9999950490537614,0,0,8
466,"4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression WP3879",0.9601592612955532,0.2993291239147593,0.012169558116387204,['MKNK2'],0.9999950490537614,0,0,1
467,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.9601592612955532,0.2993291239147593,0.012169558116387204,['HRAS'],0.9999950490537614,0,0,1
468,Notch Signaling WP268,0.9609805239232349,0.43512135573746946,0.017318324554822417,"['KCNJ5', 'NOTCH4', 'DLL3']",0.9999950490537614,0,0,3
469,Prolactin Signaling Pathway WP2037,0.9616089460246794,0.5488496057273293,0.021486041627291477,"['JUN', 'TEC', 'IRF1', 'PTPN6', 'HRAS', 'PRLR', 'YWHAG']",0.9999950490537614,0,0,7
470,Ebola Virus Pathway on Host WP4217,0.9634553597169,0.6043818423593275,0.022500606298376802,"['VPS18', 'HLA-B', 'HLA-A', 'ITGA5', 'FLNC', 'MFGE8', 'ACTB', 'CLEC4G', 'ACTG1', 'HLA-E', 'RHOB']",0.9999950490537614,0,0,11
471,RANKL/RANK signaling pathway WP2018,0.9640662904003092,0.4668356284511087,0.017083952882006242,"['JUN', 'SPI1', 'CALCR', 'PAPSS2']",0.9999950490537614,0,0,4
472,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.9640662904003092,0.4668356284511087,0.017083952882006242,"['EIF4A2', 'RPS6KA5', 'PRKCD', 'PIM1']",0.9999950490537614,0,0,4
473,Ras signaling WP4223,0.9654703113026258,0.6613367562116073,0.023239325430554254,"['SHC4', 'SHC3', 'RASA4B', 'RASGRF2', 'GAB1', 'FOXO4', 'PLD1', 'ETS1', 'RASGRP3', 'GNG3', 'HTR7', 'GNG4', 'CALM3', 'CALM1', 'FGFR4', 'CALM2', 'HRAS', 'ARF6']",0.9999950490537614,0,0,18
474,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.9661315948404454,0.42228882074156676,0.01455005739134545,"['ITGB4', 'ACTB', 'ACTG1']",0.9999950490537614,0,0,3
475,Neural Crest Cell Migration during Development WP4564,0.9661430465018301,0.36824683409760395,0.012683663603380841,"['JUN', 'EPHB3']",0.9999950490537614,0,0,2
476,miRNAs involvement in the immune response in sepsis WP4329,0.9670434556661838,0.28169831468499,0.009440230511225733,['IRF1'],0.9999950490537614,0,0,1
477,Purine metabolism and related disorders WP4224,0.9670434556661838,0.28169831468499,0.009440230511225733,['PRPS1'],0.9999950490537614,0,0,1
478,Vitamin D in inflammatory diseases WP4482,0.9670434556661838,0.28169831468499,0.009440230511225733,['DUSP1'],0.9999950490537614,0,0,1
479,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.9678851004040272,0.6422716764355604,0.020964965702983045,"['SHC4', 'LINGO1', 'JUN', 'RAB3A', 'SHC3', 'PRKCD', 'EEF2', 'ACACB', 'BMP2', 'RPS6KA5', 'CDK5', 'CFL1', 'NTF3', 'SPP1', 'HRAS', 'CDK5R1']",0.9999950490537614,0,0,16
480,Toll-like Receptor Signaling Pathway WP75,0.9681954200868824,0.5124555160142349,0.016563244778951436,"['JUN', 'TICAM2', 'CASP8', 'SPP1', 'FADD', 'TIRAP']",0.9999950490537614,0,0,6
481,TGF-beta Signaling Pathway WP366,0.9684681504589432,0.6150352148616923,0.019705532769390615,"['YAP1', 'JUN', 'CDKN1A', 'TGFB1', 'CITED1', 'ITGB4', 'FN1', 'NEDD9', 'ETS1', 'PJA1', 'PARD6A', 'CCND1', 'SKP1']",0.9999950490537614,0,0,13
482,Leptin signaling pathway WP2034,0.9691098704417508,0.5313379043600562,0.016671942519604504,"['GSK3A', 'CCND1', 'CFL2', 'LEPR', 'BAX', 'HRAS', 'ACACB']",0.9999950490537614,0,0,7
483,Interleukin-11 Signaling Pathway WP2332,0.9706358611482556,0.41018957345971563,0.012225247097135964,"['TGFB1', 'BGLAP', 'HRAS']",0.9999950490537614,0,0,3
484,Autophagy WP4923,0.9711414045821903,0.3545788188504335,0.010383200165336648,"['MAP1LC3B', 'ATG101']",0.9999950490537614,0,0,2
485,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.9711414045821903,0.3545788188504335,0.010383200165336648,"['HEXIM1', 'SUPT4H1']",0.9999950490537614,0,0,2
486,PDGFR-beta pathway WP3972,0.9711414045821903,0.3545788188504335,0.010383200165336648,"['JUN', 'HRAS']",0.9999950490537614,0,0,2
487,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.9727384286026785,0.2660264842585285,0.007352988715225239,['MAP1LC3A'],0.9999950490537614,0,0,1
488,ErbB signaling pathway WP673,0.9745424433984763,0.5515256714781656,0.014222306632410807,"['SHC4', 'CDKN1A', 'JUN', 'CDKN1B', 'SHC3', 'CCND1', 'EGF', 'GAB1', 'HRAS']",0.9999950490537614,0,0,9
489,Wnt Signaling Pathway WP363,0.9757864311028809,0.4348981717610718,0.010660022674050296,"['GSK3A', 'FRAT1', 'GCKR', 'CCND1']",0.9999950490537614,0,0,4
490,Splicing factor NOVA regulated synaptic proteins WP4148,0.9779973133854478,0.387953118995773,0.008631319103014326,"['NTNG1', 'EPB41', 'NCDN']",0.9999950490537614,0,0,3
491,MAPK Cascade WP422,0.9790880232338749,0.3300706535796452,0.0069756237834480124,"['JUN', 'HRAS']",0.9999950490537614,0,0,2
492,Neural Crest Cell Migration in Cancer WP4565,0.9790880232338749,0.3300706535796452,0.0069756237834480124,"['JUN', 'EPHB3']",0.9999950490537614,0,0,2
493,Pathways Regulating Hippo Signaling WP4540,0.9806995925232321,0.5167114086781677,0.010070236222404888,"['PRKCH', 'PRKD3', 'PRKAR1A', 'PRKCD', 'TCF7', 'CDH24', 'FGFR4', 'CDH18']",0.9999950490537614,0,0,8
494,TLR4 Signaling and Tolerance WP3851,0.9813467202626524,0.2393843725335438,0.004507475193072649,['TIRAP'],0.9999950490537614,0,0,1
495,Cardiac Hypertrophic Response WP2795,0.9814885401237428,0.4159208424235136,0.007771456490287033,"['TGFB1', 'EGF', 'CALM1', 'CALM2']",0.9999950490537614,0,0,4
496,IL-2 signaling pathway WP49,0.9822200930943579,0.3190419792077905,0.005723571106110436,"['JUN', 'HRAS']",0.9999950490537614,0,0,2
497,MECP2 and Associated Rett Syndrome WP3584,0.9823525475118555,0.4702565000097233,0.008372928913090615,"['GABRR2', 'DLX5', 'SST', 'GAD1', 'OPRK1', 'FKBP5']",0.9999950490537614,0,0,6
498,1q21.1 copy number variation syndrome WP4905,0.9845705304300338,0.22796632465140754,0.0035448176710795314,['FMO5'],0.9999950490537614,0,0,1
499,EPO Receptor Signaling WP581,0.9845705304300338,0.22796632465140754,0.0035448176710795314,['EPOR'],0.9999950490537614,0,0,1
500,Nanoparticle triggered autophagic cell death WP2509,0.9845705304300338,0.22796632465140754,0.0035448176710795314,['MAP1LC3A'],0.9999950490537614,0,0,1
501,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.9845705304300338,0.22796632465140754,0.0035448176710795314,['ADAMTS2'],0.9999950490537614,0,0,1
502,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.9848943757952379,0.3087248322147651,0.004699062468009628,"['HCK', 'TEC']",0.9999950490537614,0,0,2
503,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.9858327652202551,0.3587677725118483,0.005119095209800548,"['MAP1LC3A', 'ATG101', 'CP']",0.9999950490537614,0,0,3
504,Endoderm differentiation WP2853,0.9886398304760542,0.5305951752069026,0.006062150234225829,"['DUSP4', 'DUSP5', 'DUSP2', 'TGFB1', 'TRIM5', 'TCEAL2', 'TCF7', 'SLC2A12', 'DKK1', 'GLI2', 'NME1']",0.9999950490537614,0,0,11
505,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.989482688476945,0.34162717219589256,0.0036120272740398068,"['RPS6KA5', 'IL1R1', 'MKNK2']",0.9999950490537614,0,0,3
506,Hippo-Merlin Signaling Dysregulation WP4541,0.9911953541942952,0.4717837478686971,0.004172283609460836,"['CCND1', 'PRKAR1A', 'ITGB4', 'CDH24', 'ITGA5', 'FGFR4', 'HRAS', 'CDH18']",0.9999950490537614,0,0,8
507,Wnt signaling in kidney disease WP4150,0.9912678959566997,0.19942120494606683,0.0017490141591017805,['WNT16'],0.9999950490537614,0,0,1
508,DNA IR-damage and cellular response via ATR WP4016,0.9915631234191071,0.4279315167932579,0.003625721874298454,"['SEM1', 'FEN1', 'BRIP1', 'PCNA', 'H2AFX', 'BRCA1']",0.9999950490537614,0,0,6
509,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.9924954092709282,0.5098202883387442,0.003840421095607742,"['CLDN5', 'CLDN20', 'TGFB1', 'NOTCH4', 'ID2', 'EIF5A2', 'FN1', 'ITGA5', 'WNT16', 'HRAS', 'DLL3']",0.9999950490537614,0,0,11
510,Glycerophospholipid Biosynthetic Pathway WP2533,0.992777225318122,0.19142857142857142,0.0013876628818418162,['CDIPT'],0.9999950490537614,0,0,1
511,Lipid Metabolism Pathway WP3965,0.992777225318122,0.19142857142857142,0.0013876628818418162,['PRKAR1A'],0.9999950490537614,0,0,1
512,ESC Pluripotency Pathways WP3931,0.993015389122486,0.4603391802270419,0.0032265713816580204,"['FGF17', 'JUN', 'EGF', 'GAB1', 'FGF1', 'FGFR4', 'WNT16', 'HRAS']",0.9999950490537614,0,0,8
513,PDGF Pathway WP2526,0.9933798648006269,0.26573671974382596,0.0017650619542844224,"['JUN', 'HRAS']",0.9999950490537614,0,0,2
514,Male infertility WP4673,0.9944758960170198,0.44943318047440584,0.0024895983710203247,"['NANOS1', 'ABCB1', 'MSH5', 'DND1', 'HMGA1', 'PEX10', 'TEX15', 'ETV5']",0.9999950490537614,0,0,8
515,Regulation of Actin Cytoskeleton WP51,0.9946785496665471,0.506729241421401,0.0027037347832739624,"['FGF17', 'EGF', 'CFL2', 'TMSB4X', 'CHRM5', 'CFL1', 'FN1', 'WAS', 'FGF1', 'FGFR4', 'ACTB', 'ACTG1']",0.9999950490537614,0,0,12
516,Insulin Signaling WP481,0.9947663681534965,0.5379072681704261,0.0028226012968965582,"['XBP1', 'JUN', 'GSK3A', 'PRKCH', 'SHC3', 'RRAD', 'PRKCD', 'GAB1', 'EHD1', 'GYS2', 'RPS6KA5', 'HRAS', 'SGK2', 'VAMP2', 'ARF6']",0.9999950490537614,0,0,15
517,Chemokine signaling pathway WP3929,0.9950322572624575,0.4773069306930693,0.0023770472187290372,"['SHC4', 'HCK', 'GNG3', 'SHC3', 'CXCL12', 'GNG4', 'PRKCD', 'WAS', 'CXCL14', 'HRAS']",0.9999950490537614,0,0,10
518,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.9950583245656892,0.1772194451752463,0.0008779319972278557,['JUN'],0.9999950490537614,0,0,1
519,Kit receptor signaling pathway WP304,0.9950730295097187,0.3051578098215186,0.0015072195936186596,"['TEC', 'PTPN6', 'HRAS']",0.9999950490537614,0,0,3
520,Regulatory circuits of the STAT3 signaling pathway WP4538,0.995420249973685,0.3413670485973923,0.001566966652682164,"['GHR', 'DUSP2', 'IL3RA', 'CSF2RA']",0.9999950490537614,0,0,4
521,IL-1 signaling pathway WP195,0.9957751645163023,0.29877567140600314,0.0012649520508973594,"['JUN', 'IL1R1', 'HSPB2']",0.9999950490537614,0,0,3
522,EGF/EGFR signaling pathway WP437,0.9961000168136102,0.5259103641456583,0.002055051520752452,"['NDUFA13', 'JUN', 'PCNA', 'EGF', 'PRKCD', 'GAB1', 'PEBP1', 'FOXO4', 'PLD1', 'RPS6KA5', 'CFL1', 'SPRY2', 'HRAS', 'AP2M1', 'ARF6']",0.9999950490537614,0,0,15
523,Joubert Syndrome WP4656,0.9964852077301928,0.36189962869804765,0.0012742426806743124,"['TMEM17', 'KAT5', 'CETN2', 'UNC119', 'PDE6B']",0.9999950490537614,0,0,5
524,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.9976865478019732,0.15430149960536702,0.00035738269689284915,['GABRA6'],0.9999950490537614,0,0,1
525,Thermogenesis WP4321,0.9982733059835306,0.38399807216644843,0.0006636202731459756,"['ADCY10', 'CPT2', 'ACSL5', 'CPT1B', 'HRAS', 'ACTB', 'ACTG1']",0.9999950490537614,0,0,7
526,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.9985483423136295,0.21243146027986137,0.0003086018084684851,"['HOMER1', 'HRAS']",0.9999950490537614,0,0,2
527,Ectoderm Differentiation WP2858,0.9987986106332921,0.40878859857482186,0.0004914095217875985,"['MAFB', 'ARHGDIG', 'PIM1', 'HESX1', 'SPRY2', 'NR2F2', 'JAKMIP1', 'PTPN13', 'GLI3']",0.9999950490537614,0,0,9
528,Interferon type I signaling pathways WP585,0.9989681814608015,0.20335822462642061,0.0002099371134062828,"['RPS6KA5', 'PTPN6']",0.9999950490537614,0,0,2
529,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.9992178882705236,0.2808469100797174,0.0002197396042270845,"['TGFB1', 'EGF', 'CALM1', 'CALM2']",0.9999950490537614,0,0,4
530,Integrin-mediated Cell Adhesion WP185,0.9993501018294355,0.30591871896219724,0.0001988806488822367,"['SHC3', 'ITGB4', 'ITGA5', 'HRAS', 'MYPN']",0.9999950490537614,0,0,5
531,Mesodermal commitment pathway WP2857,0.9996898386700064,0.3337183544303797,0.00010352258383458697,"['YAP1', 'CCND1', 'PRKAR1A', 'TRIM5', 'SLC2A12', 'RPL38', 'DKK1']",0.9999950490537614,0,0,7
532,Energy Metabolism WP1541,0.999801711374894,0.10859582406543733,2.153545183432028e-05,['UCP3'],0.9999950490537614,0,0,1
533,Ciliopathies WP4803,0.9998716602860831,0.3911195087387813,5.0199387215259414e-05,"['PKHD1', 'TMEM17', 'EVC', 'ARL2BP', 'MAK', 'DCDC2', 'UNC119', 'CCDC65', 'AK7', 'DNAI1', 'GLI3', 'GLI2']",0.9999950490537614,0,0,12
534,Rett syndrome causing genes WP4312,0.9998865950480046,0.10163898638096358,1.1527017994210983e-05,['SATB2'],0.9999950490537614,0,0,1
535,Ciliary landscape WP4352,0.9999025805854393,0.43672369748620743,4.254743944084139e-05,"['YAP1', 'DYNLT3', 'H3F3A', 'COPS7A', 'IQGAP2', 'COX6C', 'DYNLL2', 'LSM4', 'PSMD8', 'EXOSC4', 'CDH23', 'TMED1', 'DYNLRB1', 'VIM', 'CALM1', 'COPS8', 'CALM2']",0.9999950490537614,0,0,17
536,Fragile X Syndrome  WP4549,0.9999079093065066,0.30593499593543144,2.817506329005479e-05,"['EEF1A1', 'HOMER1', 'PRKAR1A', 'GAD1', 'GAB1', 'AP2M1', 'SHANK1']",0.9999950490537614,0,0,7
537,mRNA Processing WP411,0.9999155327081303,0.3228588867351251,2.727216763787865e-05,"['SF3B5', 'LSM7', 'CSTF2T', 'SNRPE', 'SNU13', 'HNRNPH2', 'HNRNPAB', 'SRSF9']",0.9999950490537614,0,0,8
538,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.999992267825731,0.2124505928853755,1.642711358609295e-06,"['ABCG5', 'GSK3A', 'RPS6KA5', 'SHC3', 'HRAS']",0.9999950490537614,0,0,5
539,Genes related to primary cilium development (based on CRISPR) WP4536,0.9999950490537614,0.1457345971563981,7.215259417516882e-07,"['TMEM17', 'EVC', 'TULP3']",0.9999950490537614,0,0,3
